Private Equity Portfolio Company Fees
Private Equity Portfolio Company Fees
Private Equity Portfolio Company Fees
Research Papers
November 2015
Ludovic Phalippou
Sad Business School, University of Oxford
Christian Rauch
Sad Business School, University of Oxford
Marc Umber
Frankfurt School of Finance and Management
It is not clear exactly what these transaction fees are paying for,
since GPs should already be receiving (...) management fees. We
think of these transaction fees as just being one way that [GPs]
can earn revenue (...) It is difficult to find reliable information
about the frequency and size of these fees (...) As with transaction
fees, we think of monitoring fees as just another way for funds to
earn a revenue stream. Metrick and Yasuda (2010)
When private equity firms sponsor a takeover, they may charge fees to the target company while
some of the firms partners sit on the companys board of directors. In the wake of the global
financial crisis, such potential for conflicts of interest became a public policy focus. Google Trend
shows no searches prior to November 2009 for private equity portfolio company fees and a steady
flow of related searches thereafter. On July 21st 2015, thirteen state and city treasurers wrote to the
SEC to ask for private equity firms to reveal all of the fees that they charge investors. In August
2015 one of the largest private equity investors said that it will no longer invest in funds that do not
disclose all of their fees.1 The SEC announced on October 7th 2015, that it will continue taking
action against advisers that do not adequately disclose their fees and expenses following a
settlement by Blackstone for $39 million over so called accelerated monitoring fee issues.
Relatively little is known about private equity portfolio company fees: What are the
different types of fees, what do they pay for, how much is charged? How common are the
accelerated monitoring fees the SEC seems to focus on, are these fees a new phenomenon? Do fees
vary by GP, business cycles, or company type? Can these fees be rationalized? Using a
comprehensive hand collected dataset, this paper aims to fill this gap.
Most private equity funds are organized as limited partnerships, with private equity firms
(e.g. Blackstone, KKR) serving as general partners (GPs) of the funds, and institutional investors
providing most of the capital as limited partners (LPs). Limited Partnership Agreements (LPAs) are
signed at the funds inceptions and define the expected payments by LPs to GPs: a fixed
management fee, a carried interest which is paid if a certain return is achieved (like a call option),
and the fraction of portfolio company fees that is rebated to the LPs. Gompers and Lerner (1999) and
Metrick and Yasuda (2010) show that these fees are overall similar across GPs and over time.
When GPs find a suitable investment, they call the necessary amount of capital from LPs,
arrange the acquisition, and join the board of directors, which in turn appoints the Executive team.
We find that in most cases a Management Services Agreement (MSA) is signed between GPs and
the Executive team acting on behalf of the company. MSAs list various portfolio company fees and
the services they are associated with. Our analysis of these MSAs shows that these fees are ex-post
discretionary compensation items for GPs.
Wall Street Journal, August 6th 2015: http://www.wsj.com/articles/dutch-pension-fund-demands-full-fee-disclosurefrom-private-equity-firms-1438850122
1
1
Electronic copy available at: http://ssrn.com/abstract=2703354
As most limited partnerships last for 10 to 14 years, LPAs are necessarily incomplete
contracts. It is not only costly to write the numerous contingencies that can arise over such a long
period of time but also difficult to even foresee these contingencies. For example, five years after the
LPA is signed a financial crisis may trigger a hike in the cost of executing or monitoring LBOs. The
earliest foundations of transaction cost economics (Williamson (1971)) argue that incomplete
contracts imply the need for ex-post adaptation. The procurement literature, for example, highlights
the importance of allowing agents to charge ex-post adaptation costs (e.g. Crocker and Reynolds
(1993), Bajari and Tadelis (2001), Bajari, Houghton, and Tadelis (2014)). The solution to the
dynamic incomplete contracting problem in the private equity industry may be similar to that of the
procurement literature. We need a combination of an ex-ante contract such as the LPA, which is
standard and similar across GPs, followed by an ex-post adjustment contract such as the MSA. A
similar justification is that MSAs smooth out GPs compensation and therefore reduce GPs required
risk premium, hence enables LPs to reduce the average compensation of GPs (see, e.g. Itoh (1993)
and Holstrom and Milgrom (1990)).
This type of argument implies that portfolio company fees should be predominantly
company- and time-specific, not GP specific. For example, companies that are riskier or more
difficult to monitor should command higher fees. Fees should increase with the level of
environmental complexity (e.g. times of higher credit spreads, lower credit supply).
There are at least three other theoretical arguments that may support the view that MSAs are
part of an optimal contracting device. First, as LPs need to learn about GPs talent and pay GPs
accordingly, it may be optimal to start with a standard and low compensation, and to let GPs adjust it
upward if and when they are successful (see Berk and Green (2004), Robinson and Sensoy (2013)).
Second, GPs have less financial incentives when their carried interest is out-of-the-money; MSAs
can reset their incentives then. Similarly, when a company is in financial distress, equity holders
have less incentive to perform since some of the benefits accrue to debtholders (Myers (1977)).
Discretionary adaptation fees could solve this old problem. Third, MSAs can counteract GPs
incentive to invest in bad projects when they are getting close to their investment period deadline
(Axelson, Strmberg, and Weisbach (2009)).
These three arguments are GP-specific. They point at GPs past and current performance as
the key drivers of fee levels. The companys financial distress, and fund age at the time of LBO
inception, may also play a role. There are also predictions common to all of these optimal
contracting views. GP fund flows should be insensitive to the amount of portfolio company fees. In
addition, if these contracts are optimal then GPs should retain a meaningful portion of the portfolio
company fees they charge. Otherwise, investors lose the benefits of using MSAs in the first place.
Alternatively, these fees may be a wealth transfer. As with any wealth transfer, a stakeholder
must lose out and we identify three possible victims. First, the transfer may be at the expense of the
tax authorities. The idea, building on Polsky (2014), is that GPs transfer cash out of the company and
call it a fee rather than a dividend because fees, unlike dividends, are deductible from corporate
taxes. GPs then share the tax savings with LPs (see Appendix A for a detailed example).
Second, the transfer could target LP supervisors: e.g. regulators, the board of trustees. LPs
report to their principals the fees that they pay to the GPs. By charging fees directly to portfolio
companies instead of charging management fees to LPs, expense ratios reported by LPs are lower.
Third, these fees may be the result of tunneling as defined by Johnson et al. (2000): transfer
of resources out of a company to its controlling shareholder [GPs here] (...) via self-dealing
transactions. In that case, cash is simply withdrawn from LP investments without their consent.
This is similar to the tunneling situations explored in the literature but there is an important
difference here: the GP-LP interaction is a repeated game. If GPs divert cash away from LPs, returns
are lower, hence future funds are smaller, and future fees are lower (see Chung et al. (2012)). In
addition, LPs may notice this and drive tunneling GPs out of business.
The first two arguments imply that LPs should allocate more capital to GPs that charge more
portfolio company fees (all else equal). Under the tax tunneling view, we also expect GPs to i)
charge more at times where more taxes are being paid (i.e. in good times), in companies with larger
tax bills; ii) rebate at least 65% of the portfolio company fees because the maximum marginal
corporate tax rate is 35%. Under the LP supervisor tunneling view, we expect that i) funds charge
higher transaction fees in their first two years; and ii) GPs whose LPs have more remote supervisors
(e.g. fund of funds) charge more. The third argument implies that i) the rebate is less than 100%, ii)
that LPs invest less in funds that charge more portfolio company fees, iii) that GPs under pressure to
increase short term revenues charge more, and iv) that fees are a policy of the GP (i.e. persistent at
the GP level).
We show that it is possible, albeit at great cost, to obtain comprehensive information about
the portfolio company fees charged between 1995 and 2014: we examine 25,000 pages of relevant
SEC filings covering 1,044 GP investments in 592 Leverage Buy-Out (LBOs) transactions, whose
total enterprise value (TEVs), including add-on acquisitions, sum up to $1.1 trillion.
The sum of the transaction fees in our sample is $10 billion, representing 0.9% of aggregate
TEV. Monitoring fees sum to a similar amount. Other fees (e.g. refinancing fees) add up to $2.4
billion, but are not included in the rest of the analysis. In total, fees add up to nearly $20 billion, and
are basically equally distributed over time.
Monitoring fees are most correlated with the total EBITDA generated during the life of the
investment, whereas transaction fees are primarily related to TEV. LBO characteristics such as
industry, earnings volatility, leverage, and GP ownership explain little of the overall variation in
3
fees. Similarly, business and LBO-industry cycles have little explanatory power. Fees are not higher
at times when it is more difficult to execute or monitor LBO investments (e.g. times of high credit
spreads, low leverage; see Axelson et al. (2013)). In fact, adding time fixed effects increases Rsquared values by less than 10 percent. This evidence is not consistent with either the first
optimality argument or the tax view. Moreover, contrary to the predictions of the tax view, only
half of the companies have positive earnings before tax and these companies do not pay more fees.
Next, we document strong evidence of fee persistence at the GP level. When we control for
GP past fee policy, we find that the R-squared value doubles. Fees seem to be a GP choice.
In 2006-2008, the decision by three GPs to sell part of their own company offers another
opportunity to disentangle the tunnelling view from the contracting view. The IPO literature shows
that the cash flow performance of firms going public tends to peak around the time of their IPO,
presumably because IPO firms pump up their performance in order to fetch higher valuations at the
offering. If portfolio company fees are manipulable by GPs, we would expect them to exhibit this
pattern.
Although the decision by GPs to sell part of their company is endogenous, we note that there
are three similarly large GPs, with a similar track record who remained private. In addition, the two
types of portfolio company fees should affect GP valuation differently: on-going ten-year fixed
monitoring fee contracts have a larger impact on valuations than (one-time non-recurring)
transaction fees. If portfolio company fees are manipulable by GPs, then monitoring fees should
increase more. If the decision to sell is due to market timing, we would not expect one particular fee
to increase more than the other.
We find that the three selling GPs nearly doubled their monitoring fees while the other three
comparable GPs decreased these fees by 38% (the rest of the GPs increased them by 22%). For
transaction fees the difference is less pronounced: the three selling GPs increased them by 13%
(versus a 36% decrease for the three other large GPs and a 22% decrease for the rest of the GPs).
Subsequent performance is similar for the selling GPs and the other GPs, indicating that there was
no obvious improvement in monitoring.
As noted above, it is arguably not until the aftermath of the financial crisis that portfolio
company fees started to be public information. How did LPs react once the news was out and
information about these fees piled up?
We study the capital flow-fee sensitivity and find that the amount of capital raised post-crisis
(2009 to 2015) is strongly related to the amount of portfolio company fees charged by a GP. We
control for the amount of capital raised pre crisis and for past performance; they are both positively
related to the amount of capital raised post crisis. This means that high-fee GPs were penalized
both via the performance channel (fees mechanically reduced performance) and via the effect of
these fees per se.
If we simply rank GPs by the amount of fees they charge, we see that about half of those
charging the most have not raised a new fund since the crisis. Most of the others have raised much
smaller funds. In contrast, the GPs that charge the least have all raised a new fund, in a relatively
short time, and most of them have raised more money post-crisis than pre-crisis. Furthermore,
consistent with the news arriving post-crisis, the flow-fee sensitivity is null around the time when the
LBO occurred (pre crisis).
This evidence of LPs rewarding low-fee GPs contradicts all of the hypotheses except for the
third tunneling hypothesis. An alternative view would have to be behavioral. For example, LPs are
overreacting to information about these fees, they do not understand they and do not realize that
these fees are optimal and in their best interests. It is also possible that it is the LP principals who got
excessively worried about these fees post-crisis because of the headline risk and LPs reacted as a
result of their principals attitude rather than because the practice was not optimal.
Overall, the body of evidence is difficult to reconcile with the optimal view or the tax
view. It seems that market forces are at work similar to what Brown, Gredil, and Kaplan (2015)
argue about potential accounting manipulations by GPs. GPs that charge the highest fees tend to be
outliers, small, young, and raise significantly less capital going forward. The only caveat is that it
took two decades for market forces to manifest themselves here. Perhaps the regulatory intervention
has been decisive in helping out investors who have not generally benefitted from SEC protection.
We note however that the magnitudes of the SEC fines so far are not commensurate with the amount
of fees we document here and that GPs that have been fined are not those charging the most. Also,
expenses charged by GPs to portfolio companies may present the largest potential for conflicts of
interest. We do not have data to analyze expenses or potential kick-back arrangements but it would
be a natural follow up study.
The paper continues as follows: Section 1 describes the content of MSAs and presents the
related literature. Section 2 presents the data and key descriptive statistics. Section 3 is dedicated to
the cross-section of fees charged in different LBOs. Section 4 studies the cross-section of fees
charged by different GPs. Section 5 concludes by discussing possible future research, policy
implications, and whether portfolio company fees are a question of the past, or not.
Institutional details
Private equity comprises various types of investments: venture capital, real estate etc. The largest
category of private equity investments is Leveraged Buy-Out (LBO) whereby a fund takes control of
a company using a significant amount of debt. From the start of the global financial crisis to the end
of 2013, LBO firms have raised as much as $1 trillion of capital. Carlyle, KKR, Blackstone and
Apollo the four largest LBO firms alone have raised $100 billion dollars.2
An LBO fund is a private partnership between i) a group of asset owners (e.g. pension funds,
sovereign wealth funds) called Limited Partners (LPs) and ii) an LBO firm called General Partner
(GP). A contract is signed at the time of fund inception between a GP and its LPs: the Limited
Partnership Agreement (LPA). LPAs govern the LP-GP relationship for the life of the fund which is
at least ten years; they are described in detail in studies of Gompers and Lerner (1999) and Metrick
and Yasuda (2010) among others.
LPs commit capital to GPs and GPs are given five years to find suitable investments to spend
that committed capital. When GPs find a suitable investment, they call the necessary amount of
capital from the LPs, arrange the acquisition, and usually take control of the board of directors, i.e.
assign the majority of the seats to their employees (Cronqvist and Fahlenbrach (2013) show a
reduction in board size post-LBO by 1.3 directors to 8.3, 5.5 of which are private equity sponsor
representatives; Cornelli and Oguzhan (2015) show on average that 33% of the seats on the board
are taken by LBO sponsors after the LBO). The board of directors, in turn, appoints the executive
team. A Management Services Agreement (MSA) is then signed between GPs and the Executive
team. Figure 1 illustrates this time line.
Importantly, LPAs specify a management fee LPs need to pay GPs every quarter (about 0.5%
of capital committed per quarter), and a carried interest (20% of profits is paid to GPs if an internal
rate of return of 8% per annum net of all fees is reached). In addition, LPAs mention that portfolio
company fees may be charged and specify what fraction of each type of portfolio company fees will
be refunded. The refund, also called rebate or offset, is done by reducing the management fee due in a
given quarter. If there is more money to be refunded than management fees due then the
Amounts raised by largest 300 firms in funds that closed between 2009 and 2013.
https://www.privateequityinternational.com/uploadedFiles/Private_Equity_International/PEI/NonPagebuilder/Aliased/News_And_Analysis/2014/May/Magazine/PEI%20300%20May%202014(2).pdf
2
excess may be rolled over to the next quarter (the roll-over rules, the list of exceptions, the
methodology etc. are all specified in the LPA).
Notice that LPs do not negotiate on the content of MSAs and therefore do not negotiate the
level of the fees charged. MSAs are an-ex post contract for LPs and in practice, LPs are not shown
past MSAs.3 LPs negotiate only on management fees, carried interest, and the fraction of portfolio
company fees that is rebated against the management fees due. In other words, the possibility that
MSAs will be in place is mentioned in the LPA but the content of MSAs is not described in LPAs.
Figure 2 provides a detailed illustration of the situation at the time of the investment. LPs are
in the bottom right corner and provide cash (and additional cash is borrowed). LPs capital is
channeled via a fund, usually sitting on the Cayman Islands, and which becomes the controlling
shareholder of a company incorporated in the US. This transaction is organized, a.k.a. sponsored,
by GPs. GPs control both the board of the Cayman island fund and the board of the corporation. GPs
then de facto appoint the senior executive team, which is the same team with which they contract the
services agreements. In fact, GPs sometimes sign the MSA on behalf of both parties.
The situation of the executive team in an LBO setting is particularly interesting. On the one
hand executives are appointed by GPs, making them de facto their employees. On the other hand,
executives have a significant equity ownership and own the most junior equity tranche. Fees
represent an ex-post dilution of the executives equity ownership in the company and can
significantly reduce compensation. Each dollar of fee can cost 15 cents to executives. Executives are
thus expected to negotiate the MSA as part of their overall compensation package.4
Figure 2 does not include the lenders. At the inception of each LBO a lender signs a lending
agreement with the executives. As ex post cash transfers can be detrimental to lenders, lenders are
expected to monitor MSAs and the fees and expenses claimed by GPs. Lenders may raise the cost of
financing for GPs that charge excessive fees. This situation is reminiscent of the LBO model
presented in Axelson, Strmberg, and Weisbach (2009), where lenders act as ex-post gatekeepers.
Importantly, GPs need to raise a new fund every two to four years in order to have sufficient
capital to seize investment opportunities at any point in time. In other words, GPs need to go back to
LPs regularly to refill their credit line: the LP-GP interaction is a repeated game. Deceived LPs do
not commit to the next fund pushing that GP out of business. This disciplining force is valid as long
as a GP has a positive probability to raise a follow-on fund.
Past MSAs are not included in documents sent to current or prospective LPs. Anecdotally prominent LPs told us that
they could not obtain MSAs from GPs before 2008. From 2011, most GPs tell their LPs how much transaction and
monitoring fees they charge. Practitioners are surprised when we tell them MSAs are in SEC filings.
Anecdotally, a serial private equity executive told us that he does not accept appointments by certain GPs because their
MSAs are excessive. Another executive told us that he refused to pay GP expenses and he could afford to do this
because he was doing well and, as a result, the GP would not fire him.
3
a refinancing transaction. The department within the GP that executes this transaction might be
considered an other professional advisor in which case GPs receive both their share of the 1% of
the transaction value (as of section 4) and be refunded for the service rendered. Expenses claimed by
GPs are not disclosed and not covered in this study.
Section 12 states that the agreement is in place until 2019, i.e. for twelve years. Termination
can be triggered by mutual consent, or by a change of control or IPO, but this is up to the company,
hence the board of directors, hence the GPs (since they have majority). In this event, GPs receive a
termination fee equal to the present value of the advisory fees up to 2019 (discount rate is the riskfree rate of a maturity-matching US T-Bill). By definition the termination fee is not related to actual
work since the termination can be decided at any time and (de facto) unilaterally. The work related
to a change of control (e.g. IPO) is covered in section 4: a 1% fee can be charged for it.
Sections 15 to 17 are partly waiving fiduciary duties: for example, section 15 states that the
GPs cannot be held liable in case it has not performed any services or if the services were not
satisfactory. Those signing on behalf of the company are working for TPG and KKR: Jeffrey Liaw
was Vice President at TPG since 2005 and Jonathan Smith was at KKR since 2000.
Hospital Corporation of America (Appendix B2)
This agreement was entered on November 17, 2006. The TEV is $33 billion; it is the third largest
LBO transaction (as of 2014). Section 1 details the type of services covered by the agreement. The
work to be provided is what the GP deems reasonably necessary or appropriate; provided, however,
that no minimum number of hours is required to be devoted. A particularity of this MSA is that the
founding family receives $29 million of transaction fees while it is unclear how the founding family
can contribute to the sort of legal, accounting or advisory work listed in Section 1 of the MSA. The
monitoring fee here increases each year as a function of the growth in adjusted EBITDA and is
therefore performance dependent (rather than workload dependent). Again, all fees are split
according to the respective ownership of equity by the GPs.
Of interest is the fact that the list of refundable expenses includes the use of privately owned
airplanes, a.k.a. private jets, as determined by the party seeking reimbursement. Unlike in the
previously shown MSA, the person signing for HCA is not an employee of any of the GPs.
Harrahs Entertainment (Appendix B3)
This agreement was entered on January 28, 2008. The TEV is $27 billion; it is the fifth largest LBO
transaction to date. The MSA is similar to the two MSAs reviewed above. Section 2a seems more
explicit about allowing GPs internal costs to be invoiced to the company; hence transaction fees
come on top of the work conducted in connection to this transaction. Section 2b is an example of the
monitoring fee being the greater of a fixed amount and a fraction of EBITDA. In this case,
monitoring fees has a call option component.
9
Less common is the fact that the rate charged for subsequent fees is not specified in section
2c. Instead the amount to be charged is kept somewhat flexible: it is what would be charged by
internationally-recognized investment banks. The termination fee is rather complex here and
perhaps subjective.5 What seems particularly difficult is the calculation of the future post-acquisition
fees: it is difficult at the time of contract termination to know how many and how much post
acquisition fees would have been charged going forward. In addition, one needs to have a projection
of future yearly EBITDAs to complete the calculation.
The sections relating to fiduciary duties (5b and 6) are more extensive than in the previous
two MSAs. These sections list several potential conflicts of interest and bind the company (and
related parties) not to hold GPs liable for any of their other activities (except wilful misconduct).
All people signing this MSA are GP employees: Anthony Civale works for Apollo.
West Corporation (Appendix B4)
The agreement was entered on October 24, 2006. The TEV is $3.3 billion, and it is similar to the
others. The expense section mentions first-class air fare or charter (i.e. private jets). It lists expenses
that can be claimed by the GPs and lists all the expenses related to the transaction (i.e. payments to
advisors, accountants, lawyers etc). One distinguishing element is that the termination fee is the
present value of monitoring fees for seven years irrespective of when the contract comes to an end.
Hence the MSA could stop after nine years and there would be seven years worth of fees still to be
paid. An IPO for that company occurred in March 2013, seven years after acquisition, meaning that
the private equity firms received 14 years of monitoring fees on that investment.
Simmons 1998 and 2003 (Appendix B5 and B6)
Fenway acquired Simmons in October 1998. What is referred to as management fees here are what
we label monitoring fees. Here, the monitoring fee is pegged to net sales and charged for the
standard ten years, but with no termination fees. This MSA is different to that signed by TH Lee in
2003. TH Lee acquires 80% of the shares from Fenway, Fenway keeps 10% and management has
the remaining 10%. TH Lee is the sole beneficiary of the MSA and this MSA has the same
specificities as that of West Corporation: e.g. the termination fee computed as the present value of
seven years of monitoring fees. This is a first indication that GP characteristics may be more
important than company characteristics.
...a lump-sum amount equal to the net present value of the remaining Transaction Fee, the Monitoring Fee, the
Subsequent Fee (...) using an annual discount rate equal to the then-current rate of interest on the Companys revolving
credit facility, and assuming that EBITDA would have grown at a rate equal to the greater of (x) 6%, compounded
annually and (y) the compounded annual EBITDA growth rate for the last two completed fiscal years.
5
10
These additional payments may or may not trigger a rebate to LPs. E.g. in an SEC filing a GP called Riverside states
that partners have invoiced portfolio companies for a range of services they have performed and these payments do not
qualify for the rebate on portfolio company fees described in their LPA. Source.
http://www.nytimes.com/2015/06/14/business/retirement/when-private-equity-firms-give-retirees-the-shortend.html? r=2.
6
11
Metrick and Yasuda (2010) were the first to provide some magnitudes for transaction fees and
monitoring fees using an ad hoc survey. They do not express a particular judgement regarding these
fees, and state that these fees are: ...just another way for BO funds to earn a revenue stream. While
it may seem odd that funds are effectively paying themselves a fee to run companies that they own,
the sharing rules with LPs can make this an indirect way for the LPs to pay the GPs for their
services. From the perspective of the LPs, it should not matter whether these payments come directly
through management fees or indirectly through monitoring fees, as long as the GP can create
sufficient value to justify them. In other words, these fees are just a component of total
compensation just like the other fees. LPs should not penalize or reward GPs for charging these fees;
what matters is the total fee charged, not the amount of one of the fee components.
As pointed out by Adams, Hermalin, and Weisbach (2010), corporations are complex: to have any
traction, a model must abstract away from many features of real-life corporations. This makes it
difficult to understand the complex and multifaceted solutions of the principals problem. There may
be a contracting model that can perfectly rationalize all the aspects of the MSAs. Here we mention a
number of possible explanations that we attempt to bring to the data but we would not claim to be
comprehensive.
We begin with mechanism studied in the Industrial Organization literature. The buyout
industry seems to partly fit both the theories of three-tier hierarchies and the dynamic incomplete
contract theories used in procurement contract design.
Three-tier hierarchy models feature a principal, a supervisor and an agent, and have been
widely studied in the literature. In our context, this would be: LPs, GPs and executives respectively.
Tirole (1986) points out that the analysis of hierarchical structures does not boil down to the
compounding of basic agency costs because of the possible existence of such side contracts between
the supervisor and the agent. He introduced the possibility of collusion via implicit or explicit side
contracting between the agent and the supervisor in three-tier hierarchies. The ensuing literature
studies the conditions under which collusion may be beneficial, and when it is not, how to minimize
the negative effects. MSAs fit the definition of side-contracts in that literature but that literature does
not study a dynamic principal-supervisor-agent model in a repeated game setup. In addition, the
literature focuses on asymmetric information and information manipulation by the supervisor and the
agent in order to fool the principal. Mechanism designs developed so far may thus not apply to our
context but some of the theoretical arguments studied may still be robust in our setting. An example is
the intuition developed by Itoh (1993) and Holstrom and Milgrom (1990) that side
12
contracting may result in an efficient risk allocation between the supervisor and the principal,
allowing principals to save on risk compensation. It seems plausible that LPs allow GPs to enter
MSAs, this lowers the volatility of GP profits hence reduce GP income risk and that in turn allows
LPs to pay GPs less on average.
The procurement literature in Industrial Organization may be more directly related to the
problem at hand despite it featuring only two layers: a principal and an agent. This literature deals
with incomplete contracting in a (long-term) dynamic setting and the central question is how to
implement state contingent effort. The solution in this literature is often to have an initial minimal
and standard contract (like the LPA) and then allowing for adaption costs to be paid to the agent.
MSAs could be viewed as such adaptation tools. The empirical implications seem similar to those of
the three tier literature. If it becomes more costly to execute and monitor LBOs because of tighter
credit conditions for example, then GPs can still perform optimally their task because the extra cost
is being covered. Hence fees should be higher for riskier companies, and at times of higher LBO
environment complexity (e.g. times of credit spreads, lower credit supply etc.).
In the private equity literature, the main model of security design (or fund design) is that
elaborated by Axelson, Strmberg, and Weisbach (2009). The authors argue that the central friction
between GPs and LPs is the incentives GPs have to engage in negative net present value projects
once LPs have committed the capital. The reason is that GPs can be better off spending LPs
promised cash commitments even when it slightly hurts returns. This effect is particularly severe
when GPs get close to their five years investment deadline. Axelson, Strmberg, and Weisbach
(2009) argue that lenders act as the ex-post gate keeper to prevent GPs going for broke. They do
not allow for the presence of MSAs in their model. But MSAs could significantly counteract GPs
incentive to invest in bad projects because they offer compensation that can be performance sensitive
and is ex post LP commitment time. An empirical implication may be that ex post fees such as
portfolio company fees are higher when funds are closer to their investment deadline, i.e. when
funds are older at the time of the LBO.
A recent literature analyzes the cross section of management and carried interest fees charged
across a large sample of funds. Robinson and Sensoy (2013) show empirically that funds with higher
management and carried interest fees have higher gross-of-fees returns and similar net-of-fees return
compared to other funds. Similarly, Huther et al. (2015) show that GPs which use a more expensive
carry structure (deal by deal instead of whole fund carry) have higher returns. From that stream of
work, one may anticipate that GPs using extra layers of fees are those performing best. In a similar
vein, we could think of these ex-post discretionary fees are a way for GPs to fully capture the price
for talent. Chung et al. (2012) argue that GPs capture their talent rent by raising larger funds: fees do
not change but the basis goes up, hence profit goes up. This is reminiscent of the mechanism in the
Berk and Green (2004) model. From this literature, we conjecture that it may
13
be optimal to start with a standard and relatively low compensation and allow GPs to adjust
compensation upward using portfolio company fees if and when GPs are successful. An empirical
implication is that fees are positively and primarily related to past and current performance of GPs.
A related argument is that ex post fees can reset the incentives of GPs whose carried interest
is out-of-the-money. Similarly, if a company is in financial distress, it is well known that equityholders, hence management, has little incentive to work hard in these situations because the benefit
of their work will primarily accrue to debtholders. With an MSA in place, supervisors have a sharp
incentive to generate extra cash flows because they can be compensated for it (via increased
monitoring fees for example).8 An empirical implication may be that monitoring fees are higher
when companies are in financial distress, and when funds internal rate of returns are below 8%.
Common predictions of these optimal contracting views is that GP fund flows should be
insensitive to the amount of portfolio company fees; and that GPs should retain some of the portfolio
company fees they charge with the fraction retained not exhibiting a particular time trend.
Alternatively, these fees may be a wealth transfer. As with any wealth transfer, a stakeholder
must lose out and we identify three possible victims: tax authorities, LP supervisors, and LPs.
Tax optimization
In Tax Notes, Polsky (2014) argues that monitoring fees lack compensatory intent and are, instead,
dividends: ...monitoring fee payments are payments made by the portfolio company to benefit
shareholders in their capacity as shareholders. While the private equity firm formally receives the
monitoring fee payment, the private equity fund, which is the entity that holds shares in the portfolio
company, receives all or nearly all of the economic benefit of the monitoring fees through
management fee offsets. Thus, monitoring fees are non-compensatory payments that benefit
shareholders, also known as dividends.9
In general, tax arbitrage could be a motivation for charging both transaction and monitoring
fees. Under this view, the GP receives a special dividend at the time of investment inception
(transaction fee), and when certain events occur (e.g. fee for recapitalization, fee for asset
disposal, termination fee) in addition to a regular annual dividend (a monitoring fee). The
regular dividend is either fixed, or expressed as a fraction of EBITDA which then resembles a
dividend yield. These dividends are dressed up as services fees in order to be treated as an
expense by the company, hence be tax deductible (see Appendix A). LPs benefit as long as the
On the other hand, when the company is close to bankruptcy the supervisor could hold up principals (and debtholders)
by taking all the cash from the agent as a fee; especially in situations where the supervisor may go out of business (and
thus not raise a new fund, and not negotiate a new LPA).
Polsky (2014) bases his conclusions on the analysis of a typical MSA. He focuses on monitoring fees and
commentaries in the press by practitioners generally approved of his view.
8
14
rebate is high enough and the part of the fees that is not rebated can be seen as the compensation of
the GP for intermediating this tax saving.
We derive some empirical implications from this tax arbitrage view. All else being equal,
GPs that charge more fees offer more tax savings, and therefore should perform better, and attract
higher subsequent capital flows from LPs. In addition, more fees should be charged when companies
have positive earnings and tax payments because the tax savings are then immediate (rather than
carried forward). This prediction should hold both in the time-series (at times of larger corporate
profits) and in the cross-section. Finally, GPs should rebate at least 60% of the fees to LPs as the
maximum marginal corporate tax rate is 40%.
Fooling LP supervisors
As pointed out by Lakonishok, Shleifer, and Vishny (1992), LPs have a wide range of supervisors; it
may include regulators, board of trustees, government. By charging fees directly to portfolio
companies and reducing LP management fees, GPs affect the metric by which LP supervisors judge
LP staff. LP staff usually work for a private equity department and compete with other departments
for capital allocations (and mandate restrictions) by LP supervisors. Because past performance is a
noisy signal of future net of fees performance, LP supervisors look at other metrics such as expense
ratios. Arguably, private equity is the asset class with the highest fees and LPs may want this fact to
be minimized. Perhaps coincidentally, it is quite rare for LPs to include carried interest in their
reported expense ratios.
LPs have for the most part simply reported management fees paid. In practice, however, LPs
pay less than the amount of management fees due because of i) management fee waivers, whereby
management fees are waived and get added to carried interest instead; and ii) management fee
offsets for portfolio company fees. The more portfolio company fees are charged, the lower the
management fee called and the lower the reported expense ratio of LPs. In one of the first media
articles covering portfolio company fees, in 2011, this rationale was provided by an anonymous LP
to The Economist who was wondering why LPs would accept portfolio company fees and in
particular what the point of a portfolio company fee was if the rebate was 100%.10
Portfolio company fees may also affect Internal Rates of Returns (IRR), another metric by which LPs are judged.
When LPs invest for the first time in private equity (or after they increase their allocation sharply), they pay large
management fees in comparison to capital invested because management fees are based on capital committed. This
negatively impacts IRR in a mechanical way and this phenomenon is called the J-curve effect. If funds charge large
transaction fees for their first transactions, management fees decrease substantially and the J-curve effect diminishes.
However, if additional capital is called to pay for transaction fees, the impact on IRR is the same unless Net Asset Value
would be set to be equal to all the cpital invested including fees.
10
15
If LPs are aware of this, or ask for this, they should ask for high transaction fees at the beginning of
the funds life, and lower transaction fees for investments occurring later in the funds life as well as
lower monitoring fees (because monitoring fees occur later on in the life of the fund).
Tunneling LPs
MSAs might fit the description of tunneling as defined by Johnson et al. (2000) as the transfer of
resources out of a company to its controlling shareholder (who is typically also a top manager) and
most specifically their definition of tunneling via self-dealing transactions. In other words,
portfolio company fees could simply be cash siphoned out of companies by GPs at the expense of
LPs. GPs rebate some of this cash to LPs but keep part of it, the latter is what is being siphoned out.
Importantly, although the LP-GP relationship had been outside of the regulator prerogatives
up until 2012, there are disciplining forces in addition to the standard protections offered by US
common law code. Specifically, it is in the interest of the executive team and the lenders in each
LBO transaction to limit cash transfers from the company to the GP; they should act as a gatekeeper
when the MSA is negotiated, very much in line with the model of Axelson, Strmberg, and
Weisbach (2009).
In addition, the GP-LP interaction is a repeated game. LPs might later on notice those cash
transfers directly (or indirectly, via lower than expected returns) and then reduce their capital
allocations to GPs whose fees are deemed excessive.
The amount being tunneled would mainly depend on GPs marginal intertemporal rate of
substitution, i.e. GPs patience. Patient GPs are less likely to tunnel as they value future fee streams
more. In other words, GPs under pressure to increase short term revenues should charge more. Other
implications are that i) LPs should penalize GPs that are tunneling most, ii) fees are a policy of the
GP and should therefore be persistent at the GP level, and iii) the effective rebate rate ought to be
less than 100%. Moreover, if information about these fees became gradually public then effective
rebate rate may slowly increase over time.
16
17
2. Data
Data source
Our sample consists of U.S.-based companies that went through a Leveraged Buy-Out (LBO)
sponsored by a private equity firm. The Securities and Exchange Commission (SEC) regulations
require companies with registered securities to file reports which are then made publicly available
electronically (since 1995).11 Companies subject to an LBO must file with the SEC if they are
publicly traded when targeted (so-called public-to-private LBOs), if they end their private equity
sponsorship via an Initial Public Offering (IPO), or if they have publicly traded debt.
Our set of IPO-exited LBOs comes from the Cao and Lerner (2009) sample between 1981
and 2006, and then from Capital IQ from 2007 to 2013. We collect a list of public to private LBO
transactions using Capital IQ. The rest of our sample also comes from Capital IQ: we download all
the transactions classified as US LBOs with a TEV of $10 million or more, exclude sponsor firms
with less than five LBOs listed in Capital IQ, and select the sub-set of companies for which postLBO EBITDA is available.12
In order to compare fees across companies, we need to scale them. In practice, transaction
fees are expressed as a fraction of TEV. Requiring this information in Capital IQ reduces our sample
by one third.13
SEC filers need to declare i) material contracts such as credit agreements and MSAs, ii)
previous fiscal year related party transaction which describes any non-arms length fee agreement
(if worth more than $120,000), and iii) financial information for the preceding three years. These
filings then provide annual information on portfolio company fees. The large amount of SEC filings,
changes in company name, and the overall complexity of LBO transactions make the process tedious
and non-trivial. We collected this information ourselves and spent an average of three hours per
company. To illustrate the collection process, Appendix C shows in detail how we collected and
codified the fees for the largest LBO in our sample.
Filings do not always cover all years from inception to exit of the LBO. If an investment is
held for more than three years, has no publicly traded debt and went IPO, then we do not have
information on the initial transaction fee. We exclude 112 LBOs for which we do not know whether
a transaction fee has been paid or not and end up with 592 LBOs.
Based on the definitions set forth in Regulation S-K of the Securities and Exchange Commission.
The latter filter selects companies that had to file periodic statements with the SEC. In addition, we cross check with a
sample of public to private transactions taken from Capital IQ as these transactions often have publicly traded debt. In
addition, as Guo, Hotchkiss, and Song (2011) and Hotchkiss, Strmberg, and Smith (2012) also assembled datasets of
LBO sponsored companies that filed with the SEC, we also use their data to cross-check ours.
We rescue 40 observations by using the total asset value post LBO as reported by Capital IQ. When regressing TEV
on total asset (in the sample for which both variables are available) we observe a unit slope and an R-square of 70%.
This substitution thus appears reasonable.
11
12
13
18
We could however have a transaction fee reported in an S4 form for a public to private
transaction, then no filings up until the IPO. In this case the beginning of the fee time-series is
missing. A company may also buy back its publicly traded debt in which case the end of the timeseries is missing. We count 140 LBOs with incomplete fee information.
19
The most controversial fee is probably the termination fee (a.k.a. accelerated monitoring): of
these five types of fees it is the only type that generated a fine from the SEC (as of the end of 2015).
We observe that no termination fees are charged for as many as 72% of the LBOs. Interestingly, the
majority of MSAs have a provision for termination fees; hence GPs decide to forego this fee in most
cases. Overall, termination fees represent only 15% of the whole fee bill. Transaction fees represent
nearly half of all fees (45% for LBO + 4% for add-ons).
To put these fees into perspective we need to scale them by a measure of company size.
Transaction fees and other fees are often quoted as a function of TEV while monitoring fees tend
to be annuities and/or a function of EBITDA. We use different measures of company size: TEV
(including that of any add-on acquisition), total EBITDA generated during the life of the investment,
total sales generated during the life of the investment, and the equity deployed by LBO funds in that
transaction (again, including that of any add-on acquisition).14
Fees add up to 1.75% of TEV. The two transaction fees together represent 0.88% of TEV.
The two monitoring fees together are of similar magnitude at 0.72% of TEV. Fees are about half
when expressed as a function of sales and about twice as much when expressed as a fraction of
EBITDA.15 Specifically, fees represent 3.6% of the lifetime EBITDA, i.e. about 1% of EBITDA per
year (the average holding period is about four years). Interestingly, the relative transaction fees and
monitoring fees both coincide with the lower bound of the range that Metrick and Yasuda (2010)
gather via interviews: 1% to 2% for transaction fees, and 1% to 5% of EBITDA per year for
monitoring fees.
Table 1 Panel B shows the fees broken down per exit channel. Not surprisingly our sample
is dominated by IPO-exits but we have many exits via sales (both to strategic buyers and financial
buyers), and bankruptcies. In fact, our fraction of bankruptcies, both in number (15%) and value
(19%), are close to those reported in the literature (Hotchkiss, Strmberg, and Smith (2012) estimate
default rates at 17.9%).
All of the fees are virtually the same across exit types except for accelerated monitoring fees.
Recall also that these fees are contentious because they represent a payment for services that will not
occur. But IPO-exits are only partial exits. GPs stay involved with the companies past the IPO date;
two or three years is quite common. An explanation for the finding that GPs often forego charging
this fee and for its mere existence (paying for a service that will not be rendered) is that GPs get paid
at the time of the IPO for the monitoring they will continue to do afterwards. When the exit is not an
IPO, monitoring stops and termination fees are hardly ever charged then.
For transaction fees, the correlations are, respectively, 90%, 68%, 57%, and 81%. For monitoring fees, the correlations
are, respectively, 64%, 71%, 65%, and 58% (non-tabulated). This confirms the tight link between transaction fees and
TEV (rather than equity deployed), and that monitoring fees is more loosely related to company size, but EBITDA is
what is most closely related.
Investments being held on average for four years and TEV being about eight times yearly EBITDA, TEV is thus about
twice as much as total EBITDA.
14
15
20
Another interesting aspect is that LBOs that went bankrupt have the same transaction fees
and regular monitoring fees as the rest of the sample. These LBOs were not a priori more burdened
than other LBOs fee-wise. More generally, this indicates that there is no obvious cash transfer away
from debtholders. This is nonetheless a point of tension. There have been law suits where lenders
have accused GPs of charging excessive fees prior to companies going bankrupt. An example is
Buffets restaurant law suit which was settled for $28 million.
Table 1 Panel C shows the fees broken down per year of LBO inception. Our sample is
well distributed over time. About one third of the LBOs took place before 1998. In dollar terms
however they represent only 17% of the sample. The 1999-2002 period was relatively cold for the
LBO industry, the boom started in 2003-2004, accelerated in 2005-2006 and reached a peak in 20072008. What is striking is the consistency of the fees across these significant industry cycles: 1.74%,
1.65%, 1.91%, 1.86%, and 1.53%. We have only 19 LBOs that occurred post-crisis and fees seem
higher due to high accelerated monitoring fees. Only accelerated monitoring fees and other fees
exhibit more of a cycle, and the cycles seem to be the opposite. Accelerated monitoring fees seem
highest when other fees are lowest. Yet, there are no dramatic changes from one period to the next
for either one of these fees.
The important take away from this panel is that although portfolio companies fees started
to be widely discussed in the press and practitioner reports post-crisis, they have existed since as
far back as we can get. They are not a phenomenon that appeared in the 2004-2008 boom before
disappearing with the crisis. They have always been around and with similar magnitudes
throughout.
Table 1 Panel D lists companies that paid the most fees. The magnitudes seem large, with
the top five companies alone paying a total of $2.59 billion (in 2014 US dollars). At the top of this
ranking is TXU which is also the largest LBO to-date. The fees total $666 million even though it did
not charge any termination fees, nor add-on transaction fees. Relative to TEV, it is below the overall
sample average.
Three of these top five payers exited via an IPO (First Data Corp, HCA, Freescale
semiconductor). Harrahs entered into an IPO too but only a small part of the company was floated.
A few months later, it filed for bankruptcy. The rest of the LBOs in the complete sample paid
nearly $12 billion in fees, bringing the total to $14.5 billion. Note that all figures are brought to 2014
US dollars using the CPI index. Otherwise, we would be adding up 1990s dollars with 2014 dollars.
This has an impact on the overall amount. If we do not inflation adjust and simply add up numbers,
relative fees are the same but absolute amounts are lower by about 15%. The simple sum of the fees
for TXU for example is $572 million.
21
22
and 2012) and rebated 61% of this amount. KKR collected $2.4 billion (from 2007 to 2014) and
rebated 39% of this amount. We assume that the effective rebate rate for 1991-2008 vintage years is
50%, implying a rebated amount of $2.6 billion*50% = $1.3 billion.17
We do not know the management fees due on these funds by CalPERS. We assume that it is
2% of capital committed for five years and 1% of half of the capital invested for another five years.
We do not discount for simplicity, and obtain $5.4 billion.
The amount of management fees called by GPs would then be $5.4 billion minus $1.3 billion,
i.e. $4.1 billion. The current accounting system used by CalPERS (and most other LPs) would record
$4.1 billion of management fees paid. Note that CalPERS provide the details of the management
fees paid in its comprehensive annual report since 2003. The last fiscal year available is 2013, and
over these eleven years, management fees paid add up to exactly $4.1 billion.18
CalPERS recently reported the carried interest paid on the sample of non-liquidated funds
($3.4 billion of realized carry plus $1.7 billion of unrealized carry). We estimate a carry for all 19912008 funds and find it to be $5.3 billion. When we compare our estimate to the actual number
reported by CalPERS for the overlapping sample, we are very close and thus confident this is a good
estimate.
To sum up, CalPERS paid: $4.1 billion of management fees, $5.3 billion of carried interest,
and (estimated) portfolio company fees of $2.6 billion which they have not tracked so far. In
comparison to the two widely known fees, portfolio company fees do not seem negligible for LPs.
Fees charged by the big-4 GPs
Fees reported by the four largest GPs may offer some further economic magnitudes and data cross
checks (Appendix Table 3). Notice that GPs report fees differently compared to LPs. GPs report
management fees due whereas LPs report management fees paid (i.e. after rebate). These four GPs
earned collectively at least $15 billion of carried interest, $10.8 billion of management fees, and $3.1
billion of net monitoring and transaction fees. If Blackstone and Carlyle would also rebate about
50% of the fees, the total amount of portfolio company fees charged to companies by these four GPs
alone would be $6 billion over the last 8 years. Coincidentally, the sum of the fees charged by these
four GPs in our sample is $5.8 billion.
Portfolio company fees are economically meaningful. We also see that Carlyle collects less
portfolio company fees than the other three GPs; and that transaction fees are slightly higher than
monitoring fees, consistent with our sample descriptive statistics.
Note that we do not have the rebate figures for Carlyle and Blackstone. Note also that the average maximum rebate
rates reported in the Preqin Terms and Condition database is 80%. We do not know what rebate CalPERS effectively
received but using 50% is also consistent with the difference between the management fees we estimated were due by
CalPERS and those they reported to have paid.
To be precise, one would need to add the years 2002 and before, plus year 2014, which has not been published yet,
and subtract fees of vintage years 2009 to 2013; our estimate of the sum of this all is close to zero.
17
18
23
24
Regression analysis
We analyze the determinants of the amount of fees charged to a given company. We first set as the
dependent variable the natural logarithm of monitoring fees. The independent variables are taken
from the set of LBO characteristics shown in Table 2. We begin by analyzing the variables that are
available for all of the LBOs. The results are shown in Table 3 Panel A.
We note a strong relationship between monitoring fees and contemporaneous EBITDA. In
contrast, TEV is weakly correlated with monitoring fees. Next we note only weak relations between
fees and ownership, and even between fees and exit routes. This indicates that the overrepresentation
of IPOs in our sample is unlikely to bias our results.
As discussed above, a potential explanation for these fees is that they compensate for effort,
and effort should be higher in more difficult LBOs. As it is difficult to measure investment
difficulty we use several proxies. Axelson et al. (2013) show that a key driver of LBO volume and
pricing is credit spread. When credit spreads are narrower, executing LBOs may be easier, but we do
not find a correlation between fees and credit spreads.19 To further study the importance of business
and credit cycles, we use a more draconian approach and introduce quarter of investment inception
fixed effects. The increase in R-squared is modest (less than 10%).
Investment difficulty may vary across companies instead. To measure investment difficulty
cross-sectionally we use the following ratios: Debt to TEV (leverage), Debt to EBITDA, and TEV to
EBITDA. The idea is that investments that are more leveraged (relative to both TEV and EBITDA)
or cheaper (low TEV to EBITDA) are more like traditional LBOs. In addition, we use both the mean
and volatility of the realized growth in EBITDA, plus a dummy variable that is equal to one when
Earnings Before Tax (EBT) is negative (and zero otherwise). None of these proxies are statistically
significant. We find similar results if we use sales or EBT instead of EBITDA, or sub-samples, e.g.
only liquidated investments, only LBOs with complete fee series (non-tabulated).
Note that the tax benefits of monitoring fees are lesser when EBT is negative. Yet,
monitoring fees are slightly higher and not lower when EBT is negative. Also, we control for
industry fixed effects throughout and the impact of these fixed effects on R-squared values is
negligible (non-tabulated).
Table 3 Panel B shows the same specifications with (natural logarithm of) transaction fees
as the dependent variable. In this case, TEV is strongly correlated with the amount charged. The
statistical significance is high and the coefficient is near unity (for readability reasons we express
TEV and EBITDA in hundred of millions). The coefficient of transaction fees to TEV is about 0.75
Another important variable in the LBO literature is the spread between the ratio of EBITDA to Enterprise Value and
high yield rate. Kaplan and Strmberg (2009) propose this variable to measure the expected return on an LBO as this is
roughly a measure of return on asset minus cost of financing by high yield debt. This variable is not significant. We also
look at VIX and it is not significant either.
19
25
which shows that larger LBOs pay relatively less transaction fees. Interestingly transaction fees are
related to the number of GPs involved: they increase with the number of GPs.
Transaction fees increase with leverage, and total EBITDA generated by the investment (expost). Transaction fees decrease with the relative price paid at acquisition. The ratio of TEV to
EBITDA is low for higher value companies (rather than growth companies). Higher valued
companies also tend to have higher leverage and generate more EBITDA (once we control for TEV).
These higher valued companies are those with a relatively higher transaction fee.
LBOs with higher transaction fees are also more likely to have a negative EBT and thus not
to pay any corporate taxes going forward. The rest of the characteristics are not related to transaction
fees: exit route, time trend etc.
Perhaps surprisingly, credit spreads are not significant. Quarter fixed effects have an even
lower impact on R-squared with transaction fees than they have with monitoring fees. Transaction
fees are therefore insensitive to business and credit cycles.
We also run these specifications with fee ratios as dependent variables: Monitoring fees to
EBITDA, Transaction fees to TEV, Monitoring fees to Equity, Transaction fees to Equity. The
results are overall similar and reported in Appendix Table 4. Of notice, R-squared values drop to at
most 17% for monitoring fees (to EBITDA) and are even lower for transaction fees (to TEV),
peaking at 7%. When scaling by equity, leverage is strongly significantly positively related to fees
charged. In more highly levered investments, Limited Partners pay significantly more fees per dollar
of investment (all else equal).
To study reverse causality, we also study whether fees are related to EBITDA growth and
volatility pre-LBO, instead of looking at post LBO figures. The number of observations is lower but
results are similar: there is no relation (non-tabulated).
We conclude that neither LBO characteristics nor time-series variables are significantly
related to fee levels. Transaction fees are higher for value companies, whose LBOs may require
less effort rather than more effort, if anything, compared to more growth-like LBOs. Overall,
proxies for LBO riskiness, difficulty to monitor, tax liabilities etc. do not appear to be related to
amounts charged. This is not consistent with what either the risk-sharing or the tax hypotheses
would have predicted. If monitoring fees would compensate for efforts they would be lower in
boom times, vary across deals as a function of the industry, variability of cash flows, financial
distress etc. We do not observe this. It is similar for transaction fees. Yet, there is plenty of
variation in fees across LBOs. What explains this variation then? We now investigate whether it is
GP dependent.
< Table 3 >
< Table 4 >
26
27
transaction fees (information is not available for monitoring fees). For the other 326 funds, nothing
was mentioned about rebates which could mean that there is no rebate, or that the fund does not
charge any portfolio company fees. As virtually all GPs charge some portfolio company fees, these
missing observations probably correspond to zero rebates. Instead of assuming no rebate in those
cases, we exclude these observations and thus report an average maximum rebate rate.
In addition, there are many exceptions and rules for the calculation of the rebate. The
headline figure is therefore an upper bound by definition. To reflect this situation we label the
variable maximum rebate rate for funds of that vintage and size. Finally, the dataset is anonymous.
As the rebate rate varies little among funds of the same vintage year and size category (defined by
Preqin), we compute an average rebate for each group and assign that rate to the each fund-LBO
pair in our sample. On average the maximum fee rebate is 80%, while the interquartile range is 65%
to 100%.20
Finally, as in Acharya et al. (2013) we collect the biographies of the founding partners for
each GP and record the fraction of these partners with graduate degrees (on average 69%), with a
consulting background (on average 10%), and with an investment banking background (41%).
21
28
to the IPO are strong. However, as modelled by DeGeorge and Zeckhauser (1993) the
relationship between the decision to go public and an increase in fees might go the other way: those
GPs that experienced an unusual surge in fees decided to go public.22
In our setup, we can go some way to separate out this timing story from a manipulation
story. An additional and important aspect of this selling event is that the two types of portfolio
company fees should affect valuations differently. On-going ten-year fixed monitoring fee contracts
have a larger impact on investment company valuations than one-time past LBO fees. The latter
fees are non-recurring while the monitoring fees are future contractual obligations which will be
paid. Under the manipulation story, unlike under the timing story, monitoring fees should increase
more than transaction fees.23
Table 5 Panel A shows fees for LBOs executed prior to 2002 and for LBOs executed in
2003 or later (pooled observations per GP). In the first sub time period, the three selling GPs
charged lower monitoring fees (except for GP 2) than the other three large GPs and charged a
similar amount to the rest of the GPs.
Post-2003, we observe that monitoring fees (relative to EBITDA) increase by a staggering
81% for the three GPs that sell part of their own company. Their transaction fees also increase but
more modestly: by 13%. In contrast, the other three large GPs decreased both fees by more than one
third. The rest of the GPs increased monitoring fees relative to EBITDA by 25%, monitoring fees
relative to TEV increase by only 4%, and transaction fees relative to TEV decrease by 22%. 24
These simple statistics are in line with the prediction of the GP patience hypothesis: GPs that are
under pressure to generate high income now rather than later charge more of these discretionary and
non-transparent source of fees.
An alternative view is that when GPs prepare to sell their company, they suddenly start to
monitor more and change their monitoring fees accordingly, but not their transaction fees. However,
it is commonly believed that GPs are highly incentivized to work as much as possible via the
earning of carried interest and fees from managing future large funds (see Chung et al. (2012)). It is
difficult to think that GPs need outside shareholders to work harder. In addition, Table 5 Panel B
shows that we do not see much difference in performance between the set of GPs; except GP 1
which seems to outperform. If the GPs that went public increased monitoring, it does not seem to
trigger an increase in performance.
This hypothesis also requires that the market does not have perfect foresight regarding these fees because it would
otherwise understand and price the trade-off between more fees now and more fees later. But we note that these fees
were essentially unknown back then. There is no public information regarding these fees, they cannot be benchmarked
against that of other GPs, whether they went up over time or not etc.
One may also argue that in the manipulation story, most of the increase in fee dollars should come from an increase in
the fee percentage while in the timing story it should come from an increase in volume. Empirically, we do not observe
a significantly different increase in volume for the three selling GPs and the rest of the GPs (non-tabulated).
GP4 had large monitoring fees pre 2002 because of several quick flips: company was held for about one year then
brought public and a termination fee was charged. Hence compared to one year of EBITDA these fees were large.
22
23
24
29
Another argument is that only these three GPs had, for some reasons, the opportunity to
increase their monitoring fees and this is what triggered their decision to sell their own company. A
counter argument would be that the amount of fees to be charged is at the discretion of the GP, as
seen above, hence any GP should be able to do so. Perhaps only the largest or the GPs with the best
track record could do it. Table 5 Panel B shows that track records and amounts raised prior to the
selling decision is similar between the two sets of GPs.
We acknowledge that the experiment is imperfect. Yet, i) the significance of the economic
magnitudes; ii) the difference between monitoring and transaction fee changes; and iii) the fact that
relative performance before and after the decision to go public seems to be the same, may indicate
that GP patience plays a role in the determination of portfolio company fees.
Next, we introduce founders backgrounds since Acharya et al. (2013) show that they have a
material influence on the GP strategies.25 Having a graduate degree and a consulting background is
positively correlated with monitoring fees. Finally, we introduce more GP characteristics. None of
them are statistically significant. In particular, fund age is not related to fees. This means that none
of the optimal contracting views that relied on specific GP characteristics (past and current
performance, fund age, etc.) find empirical support. We also used a dummy variable that is one if the
fund IRR is above 8% (and zero otherwise) to proxy for GP is in the carry. This is not significant
either (non tabulated).
Panel B shows the results for transaction fees. There, persistence in fees is slightly weaker
and the R-squared is lower. GP characteristics explain less of the variations. Similarly, GPs going
public is associated with higher transaction fees but not always significantly so.
In non-tabulated results we also run F-tests for the statistical significance of fixed effects, as
in Bertrand and Schoar (2003). We find that quarter, year, industry fixed effects are all not jointly
significant. In contrast GP fixed effects are highly statistically significant. Another result we have
not tabulated yet is that GPs with more fund-of-funds as LPs charge more fees. We used another
Preqin dataset for this: it contains about 30,000 unique pairs of LP investments into a given private
equity fund. LPs are mainly pension funds, foundations and endowments, and fund of funds. This
finding could be supporting the view that portfolio company fees aim at fooling LP supervisors
because fund of fund supervisors are basically retail and small institutional investors.
25
Reduction in sample size forces us to drop the variable called GP going public as it is zero for most observations.
31
since fundraising suddenly halted, GPs could increase the amount of fees they charge to portfolio
companies to compensate. LP associations (ILPA) started to federate and became vocal about these
fees, asking that they should at least be 100% rebated to LPs. Newspaper coverage of these fees
became more prevalent. The Dodd-Franck act included a provision for the SEC to investigate
potential conflicts of interest in private equity, including an investigation of these fees. In a speech in
May 2012, the SEC said it found violations of security laws for about half of the GPs under
investigation. Two years later the SEC started to fine certain GPs. Appendix Figure 3 shows the
Google trend time-series for management service agreement. It is exactly zero all the way to
November 2009, peaks then, and stays well googled thereafter. We conjecture that from 2009
onwards, LPs and their own principals become widely aware of these fees. We can then study how
fundraising post-crisis is impacted by past fee policy.
Regression analysis: Flow-Fee sensitivity analysis around the Global Financial Crisis
As just mentioned, it is not until the aftermath of the financial crisis that portfolio company fees
started to be mentioned in the media, that LPs started to coordinate actions related to these fees, and
that the SEC started related investigations. The 2008 financial crisis may then offer an opportunity to
measure LPs reaction to portfolio company fees becoming public information.
The results in Table 8 are different from those in the preceding table. Both monitoring fees
and transaction fees are consistently negatively related to the growth in capital raised. The cross
effect between fees and distance to the crisis shows that GPs with low transaction fees closer to the
financial crisis raised even more capital (all else equal). Hence GPs that charged high transaction
fees in the earlier part of the sample and less so in the later part of the sample are not as penalized on
the fundraising front as GPs in the opposite situation (remember that transaction fees are not as
persistent as monitoring fees). We also note that the rebate rate to LPs now matters too: GPs that
rebate more raise more capital post crisis.
We still observe a strong positive relationship between growth in capital raised and past
performance. Note also that in Table 8 (as in Table 7) we clustered standard errors at the GP level.
This is fairly draconian as this effectively considers all observations from one GP to be unique.
Other choices of clustering (e.g. a double clustering on year and GP, or year and portfolio company)
lead to higher t-statistics.
The finding that higher fees coincide with significantly lower future fundraising is perhaps
the result that is most difficult to reconcile with either the tax view or the optimal contracting view.
LPs welfare is increasing in the amount charged in fees according to the tax view. In the optimal
contracting view there should be no significant relationship. It is plausible that GPs who charged
more were those facing challenges with their investments and that is why they raised less money
going forward. Yet, the effect holds after controlling for past performance. Hence LPs reaction is
32
beyond the effect of poor performance. It means that fees per se make LPs walk away from highportfolio-company-fee GPs.
Although we found strong persistence in fees, it is possible that GPs that anticipate getting
out of business just increase fees dramatically. That is, they syphon what is left on the portfolio
companies cash account. To test for this hypothesis, the fourth specification shows how changes in
capital flows relate to a change in fee. We do not see any effect.
These results may feel black box at this point. In addition, it is perhaps instructive to
provide some economic magnitudes. Panel A Table 9 lists the GPs with the lowest fees. These GPs
have a total fee to TEV ratio below 1% and a total fee to EBITDA ratio below 2%. In fact, there is a
gap between these GPs and the rest of the GPs. The GP with the highest fees in this list is at 0.8%
and 1.4%, while the next GPs (that are not on this list) are respectively at 1%, 1%, 1.1%, 1.2% (of
TEV) and at 2%, 2%, 2%, 2.1% (of EBITDA).
The GPs listed here have all raised funds post-crisis. A few of these GPs raised significantly
more post-crisis than pre-crisis and press coverage of these fundraising events indicate that these
GPs are in high demand; we illustrate this in the columns to the right of the panel.
Panel B is clearly different. We list the top quartile GPs in terms of fees although
anonymized. It is important to bear in mind that this list is indicative rather than definitive. A
number of assumptions are made to reach a per GP figure, the total fee ratio also somewhat varies as
a function of the scaling choice. We choose TEV and EBITDA based on our empirical results but
other choices lead to slightly different rankings. Finally, we only have a subset of the investments
made by a GP. There is significant persistence which gives some comfort that a sub-sample can
provide a good proxy, but it is obviously noisy.
With these caveats in mind we observe that nearly half of these top fee quartile GPs did not
raise a fund post crisis which basically means that they are out of business. Most of the GPs that did
raise a new fund raised less than pre-crisis. There are nonetheless some exceptions. From the number
of investments and TEV we see that none of the largest six GPs are part of this list. In particular,
Blackstone which is the only GP fined by the SEC on monitoring fee practices, is not part of this list.
GPs on this list tend to be small, and have low reputation.
We also note the wide dispersion in fees. GPs in Panel A charge close to zero whereas in
panel B some GPs have charged more than 10% of EBITDA and some GPs have charged more than
5% of TEV. Moreover, the number of observations per GP and amount invested by GP in Panel B
show that the large and most famous GPs are not part of this list. This indicates that the SEC has not
focused on GPs that charged extreme fees, but instead seems to have focused on famous GPs.
< Table 6 > < Table 7 >
< Table 8 > < Table 9 >
33
One quarter of the LBO funds in the database do not have a rebate rate mentioned. This can be because they do not
refund any transaction and monitoring fees, or because they do not charge any.
We also find some cyclicality in the rebate rate, with less rebating when LBO funds are raising more money (e.g. in
2007), and refund rate tends to be higher for larger funds.
Remember that 100% refunds are not really 100% refunds. If the management fees are smaller than the portfolio
company fees, which is most likely towards the end of the funds life.
26
27
28
34
Conclusion
From 2008 to 2014, the largest four private equity fund managers (called GPs) earned collectively
$16.5 billion of carried interest a performance-related fee, $10.8 billion of management fees a
fixed fee, and $2.5 billion of fees labeled net monitoring and transaction fees. In contrast to the
former two sources of fees, monitoring and transaction fees are not well documented. In addition,
these fees are contentious because they are charged by GPs to companies whose board is controlled
by these same GPs. During the 2008 financial crisis the providers of capital complained about these
fees and, as a result, many GPs announced they would refund 100% of these fees going forward.
Does this mean that fees appeared right before the crisis and disappeared right after, making our
research an anecdotal and historical case study?
First, at best 85% of these fees were rebated on average across GPs in 2011-2014. In
addition, even when a refund of 100% is mentioned, the effective refund can be less because there
are restrictions and further complications in those calculations which effectively reduce the rebated
amount. Furthermore, we find that management service agreements contain more than just
transaction fee and monitoring fee payment schedules. These agreements waive a number of GP
fiduciary duties, and allow GPs to claim wide ranging and somewhat discretionary set of expenses.
There are also several other fees that can be charged and that we have not included (e.g. break-up
and topping fees). Even a perfect 100% refund of all portfolio company fees, if ever in place, would
not solve all of the possible agency conflicts that service agreements seem to create (rather than
solve).
In addition, this paper shows that these fees are commonplace and are not a new
phenomenon. In fact from as far back as we can measure them, we see a similar amount being
charged, irrespective of business cycles. Overall, nearly $20 billion has been charged across 592
companies, representing 3.6% of all earnings (before interest, tax, debt and amortization) these
companies generated while being under GPs control. Even if these fees were to be 100% refunded
to investors going forward, we note that the amounts charged are economically relevant and
significantly impact the finances of a large number of corporations. It is important to know why and
when companies pay these fees.
Another potential take away from our work is that, perhaps coincidentally, it is not until the
SEC started to look into these agreements that practice started to change. This would give credit to
the controversial idea that regulatory intervention is necessary even when so-classified
sophisticated parties contract with one another. If we cannot provide a definite answer to this
difficult question, we may contribute to it.
In terms of more specific policy implications, our results indicate that the GPs that the SEC
has targeted so far are more big names than worst offenders. The fines amounts are also not
35
commensurate with the amount we report here. Therefore, it is either the case that these fees are
accepted and no fine is expected, or that these fees are not accepted and the fines would be expected
to be much higher.
Moreover, accelerated monitoring fees are the fees that have attracted most regulatory and
media attention. But we show that accelerated monitoring fees are basically only charged by
company going public and at the time of the IPO. If monitoring fees are accepted practice then it is
difficult to see why a fee charged at the time of the IPO which covers the monitoring of the GPs
post IPO would not be accepted. In addition, we do not observe situations in which GPs just siphon
all the cash flows out of portfolio companies via transaction or monitoring fees even when
companies are in financial distress. More generally, we do not observe any tunneling of the type
and nature documented in the literature for other industries and countries. 29 Perhaps, overall, market
forces are at work.
There are many open questions still and perhaps we raise more questions than we bring
answers. Hopefully, this first paper to study portfolio company fees and management service
agreements will catalyze further research in this field.
Our study may also be of interest to a broader literature in industrial organization. The
buyout industry seems well suited to study hierarchical agency issues; in particular, the three-tier
principal-supervisor-agent model with supervisor-agent side contracting, originally devised by Tirole
(1986). The extensive literature following Tiroles contribution is primarily theoretical and our paper
offers a first large scale empirical study of a supervisor-agent side contract. Furthermore, the
theoretical models are mainly developed in a static setting. In this paper, we show that in private
equity, the repeated interaction between the supervisor and the principal influences the nature of the
side contracts. Our empirical analysis may then inform future three tier hierarchy models in dynamic
settings.
Previous research has focused on tunneling in developing markets. E.g. Jian and Wong (2010) in China; Baek, Kang,
and Lee (2006), and Bae, Kang, and Kim (2002) in South Korea; Bertrand, Mehta, and Mullainathan (2002) and Siegel
and Choudhury (2012) in India.
29
36
References
Acharya, Viral V., Olivier Gottschalg, Moritz Hahn, and Conor Kehoe, 2013, Corporate Governance and Value
Creation: Evidence from Private Equity, Review of Financial Studies 26, 368402.
Adams, Rene B., Benjamin E. Hermalin, and Michael S. Weisbach, 2010, The Role of Boards of Directors in Corporate
Governance: A Conceptual Framework and Survey, Journal of Economic Literature 48, 58107.
Agarwal, Vikas, Naveen D. Daniel, and Narayan Y. Naik, 2009, Effect of managerial incentives and discretion on
performance of hedge funds, Journal of Finance 64, 22212256.
Arcot, Sridhar, Zsuzsanna Fluck, Jose-Miguel Gaspar, and Ulrich Hege, 2014, Fund Managers Under Pressure: Rationale
and Determinants of Secondary Buyouts, Journal of Financial Economics, forthcoming.
Axelson, Ulf, Tim Jenkinson, Per Strmberg, and Michael S. Weisbach, 2013, Borrow Cheap, Buy High? The
Determinants of Leverage and Pricing in Buyouts, Journal of Finance 68, 22232267.
Axelson, Ulf, Per Johan Strmberg, and Michael S. Weisbach, 2009, Why Are Buyouts Levered? The Financial Structure
of Private Equity Funds, Journal of Finance 64, 15491582.
Bae, Kee-Hong, Jun-Koo Kang, and Jin-Mo Kim, 2002, Tunneling or Value Added? Evidence from Mergers by Korean
Business Groups, Journal of Finance 57, 26952740.
Baek, Jae-Seung, Jun-Koo Kang, and Inmoo Lee, 2006, Business Groups and Tunneling: Evidencefrom Private Securities
Offerings by Korean Chaebols, Journal of Finance 61, 24152449.
Bajari, Patrick, Stephanie Houghton, and Steven Tadelis, 2014, Bidding for Incomplete Contracts: An Empirical
Analysis of Adaptation Costs, American Economic Review 104, 12881319.
Bajari, Patrick, and Steven Tadelis, 2001, Incentives versus transaction costs: a theory of procurement contracts, RAND
Journal of Economics 32, 387407.
Barber, Brad M., and Ayako Yasuda, 2013, Interim Fund Performance and Fundraising in Private Equity, SSRN
Electronic Journal.
Bebchuk, Lucian A., Martijn Cremers, and Urs Peyer, 2011, The CEO pay slice, Journal of Financial Economics 102,
199221.
Berk, Jonathan B., and Richard C. Green, 2004, Mutual Fund Flows and Performance in Rational Markets., Journal of
Political Economy 112, 12691295.
Bernstein, Shai, Xavier Giroud, and Richard R. Townsend, 2013, The Impact of Venture Capital Monitoring:
Evidence from a Natural Experiment, SSRN Electronic Journal.
Bertrand, Marianne, Paras Mehta, and Sendhil Mullainathan, 2002, Ferreting out tunneling: An application to Indian
business groups, Quarterly Journal of Economics 117, 121148.
Bertrand, Marianne, and Antoinette Schoar, 2003, Managing with Style: The Effect of Managers on Firm Policies,
Quarterly Journal of Economics 118, 11691208.
Brown, Gregory W., Oleg Gredil, and Steven N. Kaplan, 2015, Do Private Equity Funds Game Returns?, Working paper.
Cao, Jerry, and Josh Lerner, 2009, The performance of reverse leveraged buyouts, Journal of Financial Economics 91,
139157.
Celik, Gorkem, 2009, Mechanism design with collusive supervision, Journal of Economic Theory 144, 6995.
Celikyurt, Ugur, Merih Sevilir, and Anil Shivdasani, 2014, Venture Capitalists on Boards of Mature Public Firms, Review
of Financial Studies 27, 56101.
Chung, Ji-Woong, Berk A. Sensoy, La Stern, and Michael S. Weisbach, 2012, Pay for Performance from Future
Fund Flows: The Case of Private Equity, Review of Financial Studies 25, 32593304.
Cohn, Jonathan B., Lillian F. Mills, and Erin M. Towery, 2014, The Evolution of Capital Structure and Operating
Performance after Leveraged Buyouts: Evidence from U.S. Corporate Tax Returns Journal of Financial
Economics. Vol. 111.
Cornelli, Francesca, Zbugniew Kominek, and Alexander Ljungqvist, 2013, Monitoring Managers: Does It Matter?,
Journal of Finance, 68, 431481.
Cornelli, Francesca, and Karakas Oguzhan, 2015, CEO Turnover in LBOs: The Role of Boards, Working paper.
Crocker, Keith J., and Kenneth J. Reynolds, 1993, The efficiency of incomplete contracts: an empirical analysis of air
force engine procurement, The RAND journal of economics 24, 126146.
Cronqvist, Henrik, and Rdiger Fahlenbrach, 2013, CEO contract design: How do strong principals do it?, Journal of
Financial Economics 108, 659674.
Cronqvist, Henrik, and Mattias Nilsson, 2003, Agency Costs of Controlling Minority Shareholders, Journal of Financial
{&} Quantitative Analysis 38.
Cumming, Douglas, 2008, Contracts and exits in venture capital finance, Review of Financial Studies 21, 19471982.
DeGeorge, Francois, and Richard Zeckhauser, 1993, The Reverse LBO Decision and Firm Performance: Theory and
Evidence, Journal of Finance 48, 13231348.
Faure-Grimaud, Antoine, Jean-Jacques Laffont, and David Martimort, 2003, Collusion, Delegation and Supervision with
Soft Information, Review of Economic Studies 70, 251279.
Gabaix, Xavier, and David Laibson, 2006, Shrouded attributes, consumer myopia, and information suppression in
competitive markets, Quarterly Journal of Economics, 505540.
Goetzmann, William N., Jonathan E. Ingersoll, and Stephen A. Ross, 2003, High-Water Marks and Hedge Fund
Management Contracts, Journal of Finance 58, 16851718.
Gompers, Paul, and Josh Lerner, 1999, An analysis of compensation in the U.S. venture capital partnership, Journal of
Financial Economics 51, 344.
Guo, Shourun, Edith S. Hotchkiss, and Weihing Song, 2011, Do Buyouts (Still) Create Value?, Journal of Finance 66,
479517.
Harris, Robert S, Tim Jenkinson, and Steven N Kaplan, 2013, Private Equity Performance: What Do We Know?, Journal
of Finance, forthcoming.
Hartzell, Jay C., and Laura T. Starks, 2003, Institutional Investors and Executive Compensation, Journal of Finance
58, 23512374.
Holstrom, Bengt, and Paul Milgrom, 1990, Regulating trade among agents, Journal of Institutional and Theoretical
Economics.
Hotchkiss, Edith S, Per Johan Strmberg, and David C Smith, 2012, Private Equity and the Resolution of Financial
Distress, Unpublished working paper., SIFR.
Huther, Nicklas, David T. Robinson, Thomas Hartmann-Wendels, and Sievers Sonke, 2015, Paying for Performance in
Private Equity: Evidence from Management Contracts, Working paper.
Itoh, Hideshi, 1993, Coalitions, Incentives, and Risk Sharing, Journal of Economic Theory 60, 410427.
Jensen, Michael C., 1989, Eclipse of the public corporation, Harvard Business Review., 6174.
Jian, Ming, and T.J. Wong, 2010, Propping through related party transactions, Review of Accounting Studies 15, 70105.
Johnson, Simon, Rafael La Porta, Florencio Lopez-de-silanes, and Andrei Schleifer, 2000, Tunneling, American
Economic Review 90, 22.
Kaplan, Steven N., 2009, Good CEOs Are Underpaid, Harvard Business Review.
38
Kaplan, Steven N., and Per Johan Strmberg, 2003, Financial Contracting Theory Meets the Real World: An Empirical
Analysis of Venture Capital Contracts, Review of Economic Studies 70, 281315.
Kaplan, Steven N., and Per Johan Strmberg, 2004, Characteristics, Contracts, and Actions: Evidence from Venture
Capitalist Analyses, Journal of Finance 59, 21772210.
Kaplan, Steven N., and Per Johan Strmberg, 2009, Leveraged Buyouts and Private Equity, Journal of Economic
Perspectives 23, 121146.
Khalil, Fahad, and Jacques Lawarre, 1995, Collusive auditors, American Economic Review 85, 44246.
Kofman, Fred, and Jacques Lawarre, 1993, Collusion in hierarchical agency, Econometrica 61, 629656.
Laffont, Jean-Jacques, and David Martimort, 1997, Collusion under asymetric information, Econometrica 65, 875911.
Laffont, Jean-Jacques, and David Martimort, 2000, Mechanism design with collusion and correlation, Econometrica 68,
309342.
Lakonishok, Josef, Andrei Shleifer, and Robert W. Vishny, 1992, The Structure and Performance of the Money
Management Industry, Brookings Papers on Economic Activity 1992, Brookings Papers on Economic Activity.
Litvak, Kate, 2009, Venture Capital Limited Partnership Agreements: Understanding Compensation Arrangements,
University of Chicago Law Review, 168218.
Lopez-de-Silanes, Florencio, Ludovic Phalippou, and Oliver Gottschalg, 2013, Giants at the Gate: On the Cross-section
of Private Equity Investment Returns, Journal of Financial & Quantitative Analysis, forthcoming.
Metrick, Andrew, and Ayako Yasuda, 2010, The Economics of Private Equity Funds, Review of Financial Studies 23,
23032341.
Myers, Stewart C., 1977, Determinants of corporate borrowing, Journal of Financial Economics 5, 147175.
Phalippou, Ludovic, and Oliver Gottschalg, 2009, The Performance of Private Equity Funds, Review of Financial Studies
22, 17471776.
Polsky, Gregg D., 2014, Private Equity Monitoring Fees as Disguised Dividends: Collateral Impact, Tax Notes 142.
Robinson, David T, and Berk A Sensoy, 2013, Do Private Equity Fund Managers Earn Their Fees? Compensation,
Ownership, and Cash Flow Performance, Review of Financial Studies 26, 27602797.
Robinson, David T., and Berk A. Sensoy, 2011, Cyclicality, Performance Measurement, and Cash Flow Liquidity in
Private Equity, NBER Working Paper No. 17428.
Siegel, Jordan, and Prithwiraj Choudhury, 2012, A Reexamination of Tunneling and Business Groups: New Data and
New Methods, Review of Financial Studies 25, 17631798.
Tirole, Jean, 1986, Hierarchies and Bureaucracies: On the Role of Collusion in Organizations, Journal of Law ,
Economics & Organization 2, 181214.
Tufano, Peter, and Matthew Sevick, 1997, Board structure and fee-setting in the U.S. mutual fund industry, Journal of
Financial Economics 46, 321355.
Williamson, Oliver, 1971, The Vertical Market Integration of Production: Market Failure Considerations, 61, 112123.
39
40
41
apportioned so that (i) the KKR Manager shall receive a portion of any Transaction Fee equal to four elevenths of
such Transaction Fee (ii) the TPG Manager shall receive a portion of any Transaction Fee equal to four elevenths
of such Transaction Fee and (iii) the Goldman Manager shall receive a portion of any Transaction Fee equal to
three elevenths of such Transaction Fee. The Company, on behalf of the members of the Company Group, may
agree to pay a Transaction Fee in excess of 1% of the Transaction Value of a Transaction, subject to the consent
of the board of directors of the Company. (...)
5. In addition to any fees that may be payable to the Managers under this agreement, the Company shall, or
shall cause one or more of its affiliates to, on behalf of itself and the other members of the Company Group
(subject to paragraph 6), reimburse the Managers and their affiliates and their respective employees and agents,
from time to time upon request, for all reasonable out-of-pocket expenses incurred, including unreimbursed
expenses incurred prior to the date hereof, in connection with this retention and/or transactions contemplated by
the Merger Agreement, including travel expenses and expenses of any legal, accounting or other professional
advisors to the Managers or their affiliates. The Managers may submit monthly expense statements to the
Company or any other member of the Company Group (...)
12. This agreement shall continue in effect from year to year unless amended or terminated by mutual
consent. In addition, in connection with the consummation of a Change of Control (as defined in the Partnership
Agreement) or an IPO (as defined in the Partnership Agreement), the Company may terminate this agreement by
delivery of a written notice of termination to the Managers. In the event of such a termination by the Company of
this agreement, the Company shall pay in cash to the Managers (i) all unpaid Advisory Fees payable to such
Manager hereunder, all unpaid fees payable to such Manager pursuant to Section 4 of this agreement and all
expenses due under this agreement to such Manager with respect to periods prior to the termination date, plus (ii)
the net present value (using a discount rate equal to the yield as of such termination date on U.S. Treasury
securities of like maturity based on the times such payments would have been due) of the Advisory Fees that
would have been payable with respect to the period from the termination date through the twelfth anniversary of
the Effective Date (...) to be apportioned so that (i) the KKR Manager shall receive a portion of such fees equal to
four elevenths of the aggregate amount of such fees (ii) the TPG Manager shall receive a portion of such fees
equal to four elevenths of the aggregate amount of such fees and (iii) the Goldman Manager shall receive a
portion of such fees equal to three elevenths of the aggregate amount of such fees. (...)
15. Each party hereto waives all right to trial by jury in any action, proceeding or counterclaim (whether
based upon contract, tort or otherwise) related to or arising out of our retention pursuant to, or our performance of
the services contemplated by this agreement. (...)
17. Except in cases of gross negligence or willful misconduct, none of the Managers (...) shall have any
liability of any kind whatsoever to any member of the Company Group for any damages, losses or expenses
(including, without limitation, special, punitive, incidental or consequential damages and interest, penalties and
fees and disbursements of attorneys, accountants, investment bankers and other professional advisors) ...
If the foregoing sets forth the understanding between us, please so indicate on the enclosed signed copy of
this letter in the space provided therefor and return it to us, whereupon this letter shall constitute a binding
agreement among us. Very truly yours,
ENERGY FUTURE HOLDINGS CORP.
B y :
/ s /
J e f f r e y
L i a w
T i t l e :
A u t h o r i z e d
S i g n a t o r y
By: Texas Energy Future Capital Holdings LLC, its general partner
By: /s/ Jonathan D. Smidt
By: KKR & Co. L.L.C, its general partner
By: /s/ Marc S. Lipschultz
By: Tarrant Capital, LLC
By: /s/ Clive Bode
By: GOLDMAN, SACHS & CO.
By: /s/ Kenneth A. Pontarelli
By: LEHMAN BROTHERS INC.
By: /s/ Ashvin Rao
42
43
44
indemnify, exonerate and hold the Managers (...) free and harmless from and against any and all actions, causes
of action, suits, claims, liabilities, losses, damages and costs and out-of-pocket expenses (...) arising out of any
action, cause of action, suit, arbitration (...)provided that the foregoing indemnification rights will not be
available to the extent that any such Indemnified Liabilities arose on account of such Indemnitees willful
misconduct; and provided, further, that if and to the extent that the foregoing undertaking may be unavailable or
unenforceable for any reason (...)
6. Disclaimer and Limitation of Liability; Opportunities.
(a) Disclaimer; Standard of Care. None of the Managers nor any of their respective Manager Designee makes any
representations or warranties, express or implied, in respect of the services to be provided by the Managers or the
Manager Designees hereunder. In no event will the Managers, the Manager Designees or Indemnitees be liable to
the Company or any of its affiliates for any act, alleged act, omission or alleged omission that does not constitute
willful misconduct of the Managers or the Manager Designees as determined by a final, non-appealable
determination of a court of competent jurisdiction.
(b) Freedom to Pursue Opportunities. In recognition that the Managers, the Manager Designees and their
respective Indemnitees currently have, and will in the future have or will consider acquiring, investments in
numerous companies with respect to which the Managers, the Manager Designees or their respective
Indemnitees may serve as an advisor, a director or in some other capacity, and in recognition that each
Manager, each Manager Designee and their respective Indemnitees have myriad duties to various investors and
partners (...)
(i) The Managers, the Manager Designees and their respective Indemnitees will have the right: (A) to
directly or indirectly engage in any business (including, without limitation, any business activities or lines
of business that are the same as or similar to those pursued by, or competitive with, the Company and its
subsidiaries), (B) to directly or indirectly do business with any client or customer of the Company or its
subsidiaries, (C) to take any other action that a Manager or a Manager Designee believes in good faith is
necessary to or appropriate to fulfill its obligations as described in the first sentence of this Section 6(b),
(D) not to communicate or present potential transactions, matters or business opportunities to the
Company or any of its subsidiaries, and to pursue, directly or indirectly, any such opportunity for itself,
and to direct any such opportunity to another Person, and (E) to take any other action permitted pursuant
to Section 6.02 of the Stockholders Agreement or Article XII of the amended and restated certificate of
incorporation of the Company.
(ii) Except as provided in Section 6(a), none of the Managers, the Manager Designees nor any of their
respective Indemnitees will be liable to the Company or any of its affiliates for breach of any duty (...)
(c) Limitation of Liability. In no event will a Manager, a Manager Designee or any of their respective
Indemnitees be liable to the Company or any of its affiliates for any indirect, special, incidental or consequential
damages, including, without limitation, lost profits or savings, whether or not such damages are foreseeable... IN
WITNESS WHEREOF, (...)
HARRAHS ENTERTAINMENT, INC.
By:
/s/ Anthony Civale
Title: Director
By:
AIF VI Management, LLC, its general partner
By:
/s/ Laurie Medley
Title: Vice President
By:
Apollo Alternative Assets GP Limited, its general partner
By:
/s/ Laurie Medley
Title: Vice President
TPG CAPITAL, L.P.
By:
Tarrant Capital, LLC, its general partner
By:
/s/ Clive D. Bode
Title: Vice President
45
WEST CORPORATION
46
47
48
2007: $300 million of transaction fees and $8 million of monitoring fees (covering the period October
11 to December 31, 2007).
2009: $750k to GS, $260k to KKR, and $260k to TPG for services as advisors and dealer managers in
Note exchange offer transactions, and refinancing old notes with new Senior Secured Notes
2010: $4 million paid to GS in connection with the issuance of new Senior Secured Notes, and $7
million to GS for continued role as dealer manager and solicitation agent for the issuance of the
Note Exchange Offers initiated in 2009
2011: $17 million to GS as joint book-runner and joint lead-arranger of Senior Secured Loan facilities.
$5 million to KKR and $5 million to TPG as advisory fees for these Senior Secured Loan facilities.
2011: $13.5 million to GS as joint book-running manager and initial purchaser in the issuance of two
Senior Secured Note tranches. $800k to KKR, and $800k to TPG as co-manager, initial purchaser and
advisor for these two Senior Secured Note tranches.
2012: $1.1 million to GS as dealer-manager and solicitation agent fees in Note offer exchange
transactions. $11 million to GS as joint book-running manager and initial purchaser in three separate
Note offerings. $4 million to KKR and $4 million to TPG as co-manager, advisor and initial
purchaser in those transactions.
2013: $29 million of monitoring fees including expenses. From the fourth quarter of 2013, fees are suspended.
Exact wording: We had previously paid these fees on a quarterly basis, however, beginning with the quarterly
management fee due December 31, 2013, the Sponsor Group, while reserving the right to receive the fees,
directed EFH Corp. to suspend payments of the management fees for an indefinite period. Effective with the
Petition Date, EFH Corp. suspended allocations of such fees to TCEH and EFIH. Fees accrued as of the Petition
Date have been reclassified to liabilities subject to compromise (LSTC).
EFH filed for Chapter 11 on April 29, 2014, six months after suspending fees. Note that EFH would
successfully come out of chapter 11 then all of the suspended fees could be claimed by the GPs.
49
Annual monitoring fees contain expense reimbursements in this case, which is unusual. Given that the
monitoring fees paid are in line with the amount specified in the MSA we assume that expenses are negligible
and we simply record the above amounts as monitoring fees. When expenses are specified, we always deduct
them. All the fees above other than transaction and monitoring fees are grouped under the heading other fees.
There is also a Related Party Transaction section in the 10-K filings which is dedicated to arms-length
transactions performed with its sponsors. These transactions are not described in great detail because they are
arms length (or worth less than $120k) and we do not record them. Exact wording: Affiliates of GS Capital
Partners have from time to time engaged in commercial and investment banking and financial advisory
transactions with EFH Corp. in the normal course of business (...) affiliates of GS are party to certain commodity
and interest rate hedging transactions with EFH Corp. in the normal course of business. From time to time
affiliates of the Sponsor Group may acquire debt or debt securities issued by EFH Corp. or its subsidiaries in
open market transactions or through loan syndications.
< Appendix Table 1 >
50
of our sample: $186 million is added. Arguably, non-exited deals have a truncated time-series of fees and their
fees are biased downwards. The bias may be small as all on-going deals are at least four years old and that we
have consistently leaned on the conservative side for all fees recorded and imputed. If we use more aggressive
assumptions for all incomplete cases (e.g. assuming they all charged a termination fee, on-going fees last until
their tenth year) the total imputed would have been twice as much.
10 of these LBOs are public to private transactions; the MSA is part of the S4 form they have to file in that
situation. They did not issue public traded debt nor exited via an IPO. The rest are cases were the filings say: we
paid fees according to the MSA. We impute these fees following the MSA but include them here as incomplete
because we are not 100% certain of the amounts.
31
Again, the sum of monitoring fees after this inference is close although lower than the sum of transaction fees.
30
51
Add-on
transactions
Regular
monitoring
Accelerated
monitoring
Other
All
75%
-
19%
-
70%
-
28%
-
21%
-
84%
-
. TEV
45%
0.81%
4%
0.07%
25%
0.44%
15%
0.28%
11%
0.15%
100%
1.75%
. Sales
0.26%
0.02%
0.14%
0.09%
0.05%
0.57%
. EBITDA
1.66%
0.15%
0.91%
0.57%
0.30%
3.59%
2.87%
0.26%
1.56%
0.98%
0.52%
6.19%
TEV
LBO
transaction
Add-on
transactions
Regular
monitoring
Accelerated
monitoring
Other
Total
IPO
68
133
253
154,668
194,899
480,621
0.82%
0.73%
0.84%
0.03%
0.13%
0.06%
0.49%
0.40%
0.44%
1.39E-05
0.07%
0.45%
0.10%
0.15%
0.16%
1.44%
1.48%
1.95%
All
454
830,188
0.81%
0.07%
0.44%
0.28%
0.15%
1.75%
52
TEV
LBO
transaction
Add-on
transactions
Regular
monitoring
Accelerated
monitoring
Other
Total
1990-1998
1999-2002
163
98
138,852
90,271
0.72%
0.77%
0.25%
0.10%
0.41%
0.46%
0.16%
0.19%
0.21%
0.14%
1.74%
1.65%
2003-2004
80
118,941
1.04%
0.02%
0.39%
0.38%
0.08%
1.91%
2005-2006
66
2007-2008
28
193,413
237,731
0.82%
0.75%
0.06%
0.01%
0.46%
0.46%
0.40%
0.16%
0.12%
0.16%
1.86%
1.53%
2009-2012
19
50,981
0.85%
0.01%
0.47%
0.58%
0.18%
2.09%
454
830,188
0.81%
0.07%
0.44%
0.28%
0.15%
1.75%
All
TEV
LBO
transaction
349
302
Add-on
transactions
0
0
Regular
monitoring
238 0
168 75
Accelerated
monitoring
Other
All
% of TEV
79
59
666
604
1.29%
1.88%
89
532
1.34%
51,733
32,195
39,719
Harrah's Entertainment
30,418
223
178
402
1.32%
Freescale Semiconductor
20,230
221
92
73
385
1.91%
Total
Othercompanies
174,295
655,893
1,270
5,456
3
599
748 342
2,914 1,953
228
989
2,590
11,910
1.49%
1.82%
Total
830,188
6,725
602
3,662 2,295
1,217
14,500
1.75%
174
72 194
830,188
1,116,411
LBO
transaction
6,725
9,209
Add-on
transactions
602
707
1,116,411
9,209
818
N_obs
TEV
Complete Sample
Augmented Sample without imputed fees
454
592
592
Regular
monitoring
3,662
5,051
5,705
Accelerated
monitoring
2,295
2,425
2,425
Other
All
% of TEV
1,217
1,491
14,500
18,884
1.75%
1.69%
1,491
19,648
1.76%
53
N_obs
592
592
592
592
581
486
481
592
592
592
526
451
592
592
592
592
581
581
592
592
592
592
592
547
509
478
472
296
540
540
528
Mean
13.73
16.94
1,886
956
62.8
9.4
6.2
0.37
0.14
0.47
4.10
2.83
0.9%
1.0%
2.5%
1.9%
3.8%
3.9%
0.46
1.76
0.86
0.84
2.63
0.17
0.17
0.15
0.34
0.39
-192
0.53
-2.0
St. Dev.
29.70
34.83
4,279
2,472
16.7
4.6
4.6
0.48
0.34
0.50
2.74
3.08
0.7%
1.1%
2.9%
2.2%
3.4%
5.0%
0.50
1.05
0.16
0.24
1.20
0.26
0.33
0.13
0.28
0.49
1,762
0.50
316.8
Q1
0.23
1.24
344
151
53.1
6.4
4.0
0.00
0.00
0.00
1.95
1.11
0.4%
0.0%
0.4%
0.1%
1.1%
0.1%
0.00
1.00
0.79
0.66
2.11
0.03
0.00
0.05
0.15
0.00
-109
0.00
-5.1
Median
4.46
6.15
711
338
64.2
8.6
5.6
0.00
0.00
0.00
3.40
1.86
1.0%
0.6%
1.6%
1.1%
3.1%
1.9%
0.00
1.00
0.91
0.81
2.95
0.09
0.10
0.11
0.24
0.00
-3
1.00
7.4
Q3
12.41
16.82
1,670
876
74.2
11.4
7.4
1.00
0.00
1.00
5.97
3.44
1.4%
1.4%
3.6%
2.6%
5.5%
5.6%
1.00
2.00
0.98
0.96
3.40
0.20
0.25
0.21
0.44
1.00
59
1.00
40.0
54
0.03
0.30a
0.70
6.46
0.26
0.66
0.12c
1.92
-0.22
-0.96
0.16
1.42
0.06a
3.86
0.09
0.79
0.30
1.15
0.16
1.30a
0.58
4.32
0.33
0.82
0.09
1.37
-0.41b
-2.27
0.25b
2.16
0.06a
3.84
0.03
0.32
0.06
0.20
0.13
1.56a
0.62
7.09
0.50
1.37
0.16a
2.94
-0.19
-1.08
0.07
0.63
0.06a
3.87
0.11
1.21
0.24
0.76
0.11
1.28a
0.65
9.02
0.46
1.41
0.11b
2.03
-0.25
-1.58
0.11
1.31
0.05a
4.87
0.10
1.11
0.08
1.02a
0.63
7.96
0.49
1.34
0.12b
2.02
-0.20
-1.21
0.09
0.97
0.08a
4.23
-0.02
-0.16
Yes
Yes
0.03b
2.28
-0.04
-0.27
0.00
-0.26
0.35
1.64
0.16
1.26
-0.01
-0.27
Yes
Yes
Yes
Yes
Yes
0.07
0.92
Yes
No
No
No
No
No
No
No
No
Adjusted R-squared
0.44
0.44
0.44
0.45
0.44
0.47
0.44
0.47
N_obs
592
581
481
431
410
451
592
592
55
0.79a
10.00b
0.15
2.02
0.14
0.54
0.12a
2.93
0.14
1.16
0.13
1.46
0.03b
2.18
0.13
1.20
-0.38
-1.22
0.67a
5.99a
0.34
3.02
0.24
0.87
0.09b
2.00
0.14
1.01
0.14
1.55
0.01
0.92
0.22b
2.24
-0.48
-1.32
0.79a
9.80a
0.25
3.53
0.31
1.36
0.12a
2.94
0.18
1.18
0.14
1.33
0.02
1.25
0.29a
3.34
-0.34
-0.88
0.77a
10.13a
0.23
3.39
0.19
0.98
0.11a
2.78
0.04
0.39
0.08
1.09
0.01
0.58
0.21b
2.41
0.78a
9.39
0.24a
3.18
0.23
0.99
0.11b
2.46
0.07
0.63
0.06
0.72
-0.01
-0.28
0.13
1.20
Yes
Yes
0.04
1.58
-0.06
-0.32
-0.05b
-2.52
0.15
1.00
0.24b
2.18
-0.06a
-2.79
Yes
Yes
Yes
Yes
Yes
0.08
0.84
Yes
No
No
No
No
No
No
No
No
Adjusted R-squared
0.55
0.56
0.53
0.55
0.58
0.57
0.55
0.55
N_obs
592
581
481
431
410
451
592
592
56
57
Monitoring
Monitoring
Transaction
Monitoring
(% of EBIDTA)
(% of TEV)
Monitoring Transaction
(% of TEV)
Monitoring
Monitoring Transaction
(% of TEV)
(% of TEV)
0.92%
0.69%
0.68%
1.99%
1.02%
0.98%
20
115%
48%
43%
GP2
1.37%
0.99%
1.03%
10
2.24%
1.49%
1.16%
17
64%
50%
12%
GP3
0.77%
0.51%
0.92%
14
1.43%
0.87%
1.02%
16
85%
70%
11%
All 3 GPs
1.00%
0.69%
0.93%
33
1.81%
1.08%
1.05%
53
81%
55%
13%
3.05%
1.35%
1.44%
17
1.28%
0.98%
0.72%
22
-58%
-28%
-50%
GP5
1.35%
0.76%
0.78%
1.30%
0.52%
0.85%
15
-4%
-32%
8%
GP6
1.42%
0.83%
1.59%
13
1.37%
0.53%
0.96%
12
-4%
-36%
-40%
All 3 GPs
2.00%
1.03%
1.31%
38
1.30%
0.70%
0.84%
49
-35%
-32%
-36%
Rest of GPs
1.27%
0.66%
1.15%
484
1.59%
0.69%
0.90%
325
25%
4%
-22%
58
Panel B: Change in capital flows and performance for the largest six GPs
Funds with vintage year 2004 or earlier
Funds with vintage year 2005 to 2012
Total raised
Average Multiple Average IRR Total raised
Average Multiple Average IRR
GPs going public
GP 1
11.97
2.31
23.08
30.03
1.78
17.06
GP 2
14.29
2.05
22.57
37.90
1.38
10.08
2.45
15.61
44.94
1.47
10.73
GP 3
25.56
10.96
2.08
19.37
29.55
1.42
8.34
GP 5
11.02
2.17
20.33
47.65
1.48
10.43
GP 6
15.12
2.26
20.73
47.02
1.38
9.88
59
-1.12a
-6.10b
0.44
2.38
-0.42
-1.60
0.71a
2.93
-2.41a
-2.76
0.35a
3.18
-0.11
-0.49
0.03
0.80
1.98a
3.47
1.08a
2.88
0.89a
8.84
GP lacks reputation
-1.09a
-5.87b
0.45
2.20
-0.25
-0.92
0.80a
3.17
-2.39a
-2.67
0.40a
3.20
-0.01
-0.05
0.03
0.71
1.86a
3.04
1.13a
3.10
0.97a
9.78
0.70a
3.06
GP age
-1.06a
-5.02b
0.46
2.40
-0.45c
-1.81
0.38c
1.93
-2.20b
-2.41
0.45a
3.42
-0.22
-1.08
0.08
1.10
2.30a
3.77
0.99a
2.70
-0.04b
-2.08
-1.18a
-4.68b
0.45
2.30
-0.50c
-1.94
0.43c
1.76
-2.56b
-2.09
0.41a
2.93
-0.02
-0.08
0.07
1.33
2.18a
2.78
-0.91a
-3.25b
0.62
2.25
-0.15
-0.43
0.78b
2.33
-2.07
-1.42
0.49b
2.50
-0.54
-1.57
0.12
1.48
1.43
1.62
0.96b
2.20
1.48a
2.75
0.24
0.43
GPfundage
Yes
Yes
Yes
Yes
Yes
-0.13
-1.35
-0.30
-1.24
0.33
0.81
-1.01
-1.50
0.09
0.12
-0.41
-0.37
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Adjusted R-squared
0.17
0.36
0.41
0.21
0.22
0.20
N_obs
1044
669
561
832
595
451
60
0.13c
1.93
-0.05
-0.65
-0.04
-0.35
0.12
1.35
-0.73b
-2.17
0.11b
2.07
0.00
-0.01
0.01
0.41
0.28
1.29
0.23b
2.26
0.44a
8.11
GP lacks reputation
0.15c
1.86
-0.08
-0.87
0.00
0.02
0.15c
1.81
-0.51
-1.47
0.12b
2.25
0.03
0.39
-0.01
-0.47
0.21
0.83
0.23b
2.39
0.46a
7.22
0.14
1.29
GPage
0.20b
2.51
-0.02
-0.25
-0.17
-1.53
0.05
0.63
-0.95a
-2.68
0.14a
2.78
0.02
0.22
-0.05a
-2.60
0.42c
1.91
0.17
1.47
0.15c
1.69
-0.03
-0.37
-0.08
-0.58
0.02
0.23
-1.06b
-2.45
0.07
1.17
0.10
1.05
-0.03
-1.54
0.06
0.22
0.20b
2.31
-0.01
-0.06
0.02
0.18
0.09
1.07
-0.30
-0.76
0.12b
2.04
-0.07
-0.68
-0.02
-0.85
-0.07
-0.26
-0.01c
-1.95
0.21
1.27
0.03
0.18
0.10
0.68
Yes
Yes
Yes
Yes
Yes
0.05
1.45
0.00
0.02
0.11
0.84
-0.13
-0.67
0.52b
2.27
-0.15
-0.41
Yes
Yes
0.11
Yes
0.20
Yes
0.20
Yes
0.11
Yes
0.12
Yes
0.15
N_obs
1044
669
561
832
595
451
61
Yes
Yes
-0.02
-0.83
-0.06
-1.15
-0.12
-1.03
0.01
0.13
-0.04
-0.44
0.07
1.16
0.05
0.17
-0.13
-0.58
0.29
1.19
-0.03a
-2.61
-0.14b
-2.17
0.08
0.17
0.91a
6.02
Yes
-0.02
-0.87
-0.03
-0.51
-0.05
-0.38
0.16
1.64
0.05
0.57
0.07
1.04
0.17
0.52
-0.15
-0.62
0.37
1.37
-0.02
-1.38
-0.22a
-3.07
-0.02
-0.87
-0.03
-0.51
-0.05
-0.38
0.16
1.62
0.05
0.55
0.07
1.07
0.16
0.51
-0.15
-0.61
0.39
1.31
-0.02
-1.37
-0.22a
-3.07
0.10
0.22
Yes
Yes
Yes
Adjusted R-squared
0.35
0.35
0.44
N_obs
761
761
681
62
-0.03b
-2.54
-0.12b
-2.43
-0.04a
-2.70
0.06
0.28
1.29c
1.74
0.00
-0.01
0.14a
3.03
-0.03
-0.74
0.00
-0.09
0.11
0.60
0.05
0.45
0.31a
3.57
0.01
1.35
-0.11b
-2.57
0.33c
1.92
-0.02b
-2.27
-0.08b
-2.14
-0.02c
-1.84
0.08
0.47
1.03c
1.89
-0.06
-1.27
0.11a
2.94
-0.03
-0.71
0.00
-0.06
0.04
0.23
0.07
0.62
0.23b
2.25
0.01
0.86
-0.13a
-3.14
0.42b
2.53
0.89a
5.48
Yes
Yes
Yes
-0.02
-1.56
-0.12
-0.44
0.32
0.46
-0.03
-0.61
0.09b
2.28
-0.03
-0.69
-0.02
-0.57
0.25
1.45
0.05
0.38
0.18
1.56
0.01c
1.80
-0.13a
-2.83
0.34c
1.95
0.91a
5.17
-0.48
-0.31
-1.59
-0.35
Yes
Adjusted R-squared
Yes
0.12
Yes
0.13
Yes
0.37
Yes
0.34
N_obs
766
727
708
583
-0.03b
-2.24
-0.13a
-2.62
-0.03
-1.49
-0.05
-0.29
1.37b
1.97
0.01
0.08
0.11a
2.64
-0.02
-0.39
-0.01
-0.38
0.08
0.45
0.04
0.32
0.27a
3.09
0.01
1.44
-0.10b
-2.44
63
Post crisis
Size and vintage years of flagship funds
fundraising
64
Panel B: GPs charging the highest amount of portfolio company fees compared to TEV
Post crisis fundraising
Fees/TEV
Fees/EBITDA
N_obs
TEV
GP1
Out of Business
0.077
0.136
403
GP2
Large Decrease
0.072
0.141
267
GP3
Out of Business
0.066
0.096
639
GP4
Stable
0.062
0.145
283
GP5
Out of Business
0.058
0.084
500
GP6
Stable
0.051
0.137
860
GP7
Out of Business
0.047
0.109
182
GP8
Decrease
0.042
0.079
1271
GP9
Decrease
0.041
0.063
10
2276
GP10
Increase
0.040
0.083
581
GP11
Large Decrease
0.039
0.029
187
GP12
Decrease
0.038
0.057
950
GP13
Decrease
0.037
0.074
13
5510
GP14
Large Decrease
0.035
0.069
1206
GP15
Stable
0.034
0.075
492
GP16
Large Decrease
0.034
0.045
426
GP17
Out of Business
0.033
0.083
929
GP18
Out of Business
0.033
0.057
2302
GP19
Out of Business
0.032
0.036
1597
GP20
Stable
0.030
0.110
320
GP21
Large Decrease
0.030
0.086
10
3322
GP22
Out of Business
0.030
0.057
1797
GP23
Out of Business
0.029
0.043
16
3813
GP24
Out of Business
0.029
0.058
3991
GP25
Out of Business
0.029
0.020
926
GP26
Decrease
0.028
0.065
13309
GP27
Decrease
0.026
0.032
194
GP28
Out of Business
0.026
0.085
10
15202
GP29
Out of Business
0.026
0.045
1411
65
Vintage years
2000-2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
All
N_funds
20
14
23
31
39
32
29
57
51
45
35
13
389
All
82.63
77.64
72.61
71.13
69.03
79.69
76.55
74.91
85.33
84.89
86.34
85.38
78.79
All
0.23
0.27
0.40
0.10
-16.27b
-2.26
-11.65c
-1.74
4.22a
4.11
yes
-5.32b
-2.15
-5.94b
-2.05
-15.30a
-2.60
-7.10a
-2.72
-13.89c
-1.91
4.54a
3.37
yes
16
15
21
285
285
285
-7.33a
-2.76
4.71a
4.44
yes
2.85b
2.19
yes
4.17a
4.07
yes
16
15
15
285
285
285
4.54a
4.25
yes
66
Pre2000
Post2000
Small
Large
91.3
0.6
1.6
0.6
0.6
0.6
0.0
0.6
4.4
0.0
79.3
5.6
1.1
1.9
0.4
4.4
3.3
0.7
2.2
1.1
91.2
0.4
0.9
0.9
0.4
0.4
0.9
0.0
4.0
0.9
76.9
6.7
1.8
1.8
0.4
5.3
3.1
1.3
2.2
0.4
5.1
3.3
34.8
5.4
46.7
2.2
2.5
3.4
1.8
13.5
9.8
52.8
14.7
4.0
2.8
3.2
29.4
7.1
50.8
2.4
4.3
3.1
1.6
13.2
9.3
50.4
17.8
4.7
1.1
9.8
16.3
72.8
38.0
11.8
10.1
40.2
3.9
10.1
14.7
71.3
45.1
12.0
9.9
33.1
67
Status
Exited
Exited
Exited
Exited
Exited
Exited
Exited
Exited
Exited
Exited
Not exited
Not exited
Not exited
Not exited
Not exited
Not exited
Not exited
Available
Missing
Available
Available
Only 1st year missing
Available
Missing
Available
Only 1st year missing
Missing
Available
Available
Available
Missing
Available
Only 1st year missing
Only 1st year missing
Monitoring fee
4,586
62
733
161
402
55
77
57
123
5
756
121
287
0
20
21
10
7,476
Amount imputed
0
435
0
110
0
0
29
0
0
3
0
0
168
19
0
0
0
765
Observations classified
as complete
Yes
No
Yes
No
Yes
Yes
No
Yes
Yes
No
No
No
No
No
No
No
No
68
2007
2008
2009
2010
2011
2012
2013
2014
2008-2014
149
208
-117
90
657
897
245
330
-209
121
-845
-479
261
148
-99
49
311
621
259
163
-101
60
1,322
1,641
263
156
-98
58
-449
-128
277
276
-154
122
1,668
2,066
285
na
na
78
2,517
2,880
315
na
na
58
232
605
1,905
1,073
-661
546
4,756
7,206
255
124
380
759
269
52
-430
-110
271
86
338
695
263
72
309
644
332
133
71
536
349
100
258
707
368
97
728
1,193
416
135
1,977
2,528
2,268
675
3,251
6,193
na
na
na
na
na
na
523
14
20
34
-688
-132
536
16
12
28
495
1,059
538
15
22
36
1,264
1,838
511
31
35
66
854
1,431
496
18
19
37
770
1,303
472
23
21
44
1,874
2,389
565
18
51
69
1,354
1,988
3,641
135
180
314
5,923
9,876
258
70
683
-231
523
261
1,042
396
97
23
-13
108
-1,160
-656
415
158
58
-74
142
746
1,303
396
87
96
-53
130
605
1,131
430
164
167
-145
186
139
755
424
117
97
-97
116
684
1,223
460
120
150
-137
134
794
1,387
453
135
215
-199
151
777
1,381
2,974
878
806
-718
967
2,585
6,524
69
0.01
0.38
0.06a 1.61a
-0.53 -1.03
-2.96 -4.06
1.12
0.40
1.35
0.47
0.31a 0.28b
3.13
2.14
-0.25 -0.75a
-0.75 -2.67
0.61a 0.61a
2.71
2.60
0.07b 0.08b
2.55
2.46
-0.03 -0.18
-0.13 -0.89
0.70c 0.42
1.65
0.61
0.26
1.44
-0.78a
-3.97
0.98
1.41
0.36a
2.97
-0.65b
-1.97
0.30
1.44
0.07b
2.26
0.07
0.40
0.90
1.44
0.29c
1.76
-0.78a
-5.12
1.24b
1.98
0.31a
2.74
-0.61b
-2.36
0.34c
1.92
0.06a
2.64
0.06
0.38
0.28
1.59
-0.86a
-5.12
1.28c
1.82
0.32b
2.50
-0.50c
-1.81
0.23
1.20
0.11b
2.31
-0.05
-0.29
Yes
Yes
0.08c
1.76
0.31
0.72
0.00
-0.11
0.48
0.96
0.25
1.11
-0.01
-0.28
Yes
Yes
Yes
Yes
Yes
-0.08
-0.46
Yes
No
No
No
No
No
No
No
No
AdjustedR-squared
0.12
0.11
0.14
0.15
0.17
0.15
0.11
0.14
N_obs
592
581
481
431
410
451
592
592
70
-0.12b
-2.00a
0.15
2.85
0.30
1.60
0.06c
1.80
-0.05
-0.56
0.05
0.75
0.01
0.69
0.18a
2.94
-0.05
-0.36
Leverage (*100)
-0.11c
-1.89a
0.14
2.73
0.32c
1.67
0.05
1.62
-0.04
-0.45
0.05
0.76
0.00
0.50
0.16b
2.45
-0.01
-0.09
0.00
1.00
-0.16b
-2.48a
0.15
2.73
0.24
1.15
0.08a
2.59
0.04
0.42
0.08
1.23
0.01
1.49
0.09
1.33
-0.07
-0.45
-0.13b
-2.16c
0.10
1.81
0.35
1.61
0.08b
2.48
0.07
0.74
0.08
1.14
0.01
1.37
0.07
0.99
-0.10
-0.67
0.00
-0.50
0.02
1.12
0.06
0.43
-0.03b
-2.21
EBITDA CAGR
LBO TEV to LTM EBITDA
Volatility of EBITDA over Total Asset
Total EBT is negative (1/0)
Holding period
-0.19a
-2.74a
0.21
2.76
0.39
1.61
0.06c
1.78
0.08
0.82
0.13
1.58
0.00
0.35
0.14b
2.13
-0.21
-1.08
-0.08
-1.53a
0.17
3.48
0.21
1.02
0.06c
1.77
0.04
0.37
0.14
1.55
0.01
0.64
0.24a
3.71
0.00
-0.02
-0.12b
-2.00a
0.15
2.86
0.30
1.57
0.06c
1.80
-0.05
-0.54
0.05
0.74
0.00
0.62
0.18a
2.94
-0.12c
-1.84a
0.16
2.78
0.36c
1.80
0.06c
1.80
-0.03
-0.33
0.03
0.48
-0.01
-0.68
0.14c
1.87
Yes
Yes
0.18c
1.71
0.10
1.26
-0.04b
-2.41
Yes
Yes
Yes
Yes
Yes
-0.01
-0.14
Yes
No
No
No
No
No
No
No
No
Adjusted R-squared
0.05
0.05
0.06
0.05
0.05
0.07
0.05
0.03
N_obs
592
581
481
431
410
451
592
592
71
-2.98a
-9.09a
2.64
8.71
-2.82c
-1.71
0.21
0.90
-0.33
-0.57
0.46
1.48
0.04
0.65
0.04
0.11
1.17
1.20
Leverage (*100)
-3.04a
-9.27a
2.30
7.98
-3.30b
-2.17
0.19
0.80
-0.78
-1.42
0.80a
2.67
0.09c
1.73
-0.03
-0.09
1.77c
1.86
0.10a
8.12
-3.18a
-7.91a
2.89
7.88
-3.35c
-1.86
0.34
1.63
-0.11
-0.19
0.66c
1.82
0.11c
1.96
0.07
0.18
0.45
0.55
-3.12a
-7.56a
2.64
6.93
-4.81b
-2.37
0.32
1.46
-0.14
-0.20
0.91b
2.09
0.15b
2.30
-0.06
-0.13
0.40
0.50
0.09c
1.68
0.33c
1.94
-0.87
-1.61
-0.26b
-2.14
EBITDA CAGR
LBO TEV to LTM EBITDA
Volatility of EBITDA over Total Asset
Total EBT is negative (1/0)
Holding period
-3.09a
-6.55a
2.44
4.68
-4.91b
-2.22
0.29
0.99
-0.65
-0.93
1.20a
3.01
0.12c
1.78
-0.28
-0.61
0.78
0.65
-3.03a
-8.17a
2.78
7.80
-3.31c
-1.87
0.34
1.26
-0.20
-0.27
0.25
0.55
0.08
1.22
-0.19
-0.50
0.57
0.57
-2.99a
-9.09a
2.65
8.75
-2.74c
-1.66
0.21
0.90
-0.36
-0.62
0.46
1.48
0.07
1.52
0.03
0.09
-3.31a
-9.87a
2.65
8.31
-2.19
-1.14
0.25
0.93
0.02
0.03
0.44
1.20
0.17c
1.67
-0.14
-0.34
Yes
Yes
2.39b
2.17
0.60
1.01
0.08
0.72
Yes
Yes
Yes
Yes
Yes
-0.11
-0.22
Yes
No
No
No
No
No
No
No
No
Adjusted R-squared
0.05
0.05
0.06
0.05
0.05
0.07
0.05
0.03
N_obs
592
581
481
431
410
451
592
592
72
-0.22
-0.93
0.91a
4.05
-2.67a
-2.81
0.12
0.83
0.57
1.54
-0.08
-0.28
-0.08b
-2.21
0.59b
2.01
-0.78
-1.61
Leverage (*100)
-0.29
-1.22
0.57a
2.81
-3.15a
-3.38
0.10
0.67
0.13
0.39
0.26
1.06
-0.03
-0.73
0.51b
2.08
-0.18
-0.35
0.09a
11.11
-0.62b
-2.41
1.08a
4.51
-2.82b
-2.55
0.29b
2.09
0.95b
2.44
0.28
0.96
0.00
-0.05
0.42
1.28
-1.29b
-2.49
-0.34
-1.38
0.64a
2.64
-2.87b
-2.33
0.26c
1.88
1.09a
2.64
0.35
1.19
0.00
0.13
0.21
0.65
-1.45a
-2.72
0.03
0.89
0.28
1.62
-0.40
-0.80
-0.33a
-2.75
EBITDA CAGR
LBO TEV to LTM EBITDA
Volatility of EBITDA over Total Asset
-0.69b
-2.04
1.32a
3.43
-3.36b
-2.46
0.15
1.01
1.29a
2.91
0.11
0.32
-0.08b
-2.41
0.58c
1.69
-1.54a
-2.83
-0.15
-0.55
1.08a
4.46
-3.12a
-3.19
0.08
0.52
0.71
1.48
0.38
0.99
-0.08c
-1.89
0.71b
2.37
-1.18c
-1.74
-0.21
-0.87
0.90a
4.03
-2.73a
-2.82
0.12
0.83
0.59
1.62
-0.08
-0.29
-0.10a
-3.18
0.59b
2.00
-0.30
-1.15
0.89a
3.74
-2.52b
-2.49
0.17
1.06
0.76c
1.91
0.05
0.16
-0.18a
-3.33
0.51
1.45
Yes
Yes
0.48
0.79
0.46
1.12
-0.19b
-2.42
Yes
Yes
Yes
Yes
Yes
-0.35
-1.12
Yes
No
No
No
No
No
No
No
No
Adjusted R-squared
0.09
0.28
0.09
0.14
0.12
0.12
0.09
0.09
N_obs
581
581
481
431
403
444
581
581
73
GP sponsors
investment #1 in
Portfolio Company A
74
Board of directors
General Partner
New York City
Repeated interaction
future capital commitment
Control
Appoint
Services Aggreement
fees & expenses
Pay standard
fees
LBO Fund
Cayman island
hareholderT
Executives
Portfolio Company (PC)
Delaware
Pension Funds, Sovereign
75
76